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ABSTRACT 
Vitamins are sensitive and unstable when exposed to inappropriate temperature, oxygen, light 
and humidity conditions. For the food industry it is important to reduce some of these limitations 
and being with nanosystems arise a promising solution.   
This work aims at the development of nanosystems for the encapsulation of riboflavin (water-
soluble) and α-tocopherol (liposoluble) using biopolymer and their further characterization. For 
encapsulation of riboflavin an ionotropic polyelectrolyte pre-gelation was used as production 
method being chitosan and alginate used as main materials. ( )-α-tocopherol was encapsulated 
through the self-assembly of zein, one of the major proteins of corn with an amphiphilic 
character. 
Initially a preliminary study was done to determine the optimal concentrations of biopolymers 
used and encapsulated vitamin that allow the highest efficiency and the production of nano-sized 
structures. For the alginate and chitosan system the optimal concentrations were 0.63 of 
alginate, 0.4 of chitosan and 0.065 mg/ml of riboflavin. For the zein system 2 and 1 mg/ml of 
zein and ( )-α-tocopherol, respectively, were used. Nanosystems were characterized in terms of 
average size, polydispersity index and zeta potential (through Dynamic Light Scattering) and 
vitamin entrapment efficiency. The average size (by number) for alginate/chitosan nanoparticles 
with riboflavin was 110.17 (± 47.71) nm. The nanosystems present values of polydispersity index 
and the zeta potential of 0.520 (± 0.041) and -29.64 (± 0.97) mV, respectively. Zein 
nanoparticles with ( )-α-tocopherol present an average size of 93.60 (± 1.09) nm and a 
polydispersity index of 0.222 (±0.020) with a zeta potential of +26.08 (± 2.51) mV. Both 
nanosystems have successful with encapsulation of vitamins, being the values of encapsulation 
efficiency (EE) and loading capacity (LC) obtained for (-)-riboflavin 55.91 (  5.56) % and 
2.18 (  0.63) %, respectively, and for ( )-α-tocopherol was 94.95(   4.17) % of EE and 
8.53(   1.90) % of LC. In order to complete the characterization of the nanoparticles was also 
done release profiles was also done for both vitamins and the diffusion coefficient (D) was 
calculated based on the fitting of model: for (-)-riboflavin at 37 °C D was 2.28     -   m  s at pH 
7 and 4.95   0.74     -   m  s at pH 2, and at 25 °C D was 1.02     -   m  s and 
1.88     -   m  s for pH 7 and 2, respectively; for ( )-α-tocopherol encapsulated into zein 
nanoparticles at 37°C pH 7, the ( )-α-tocopherol is not released and at pH 2 D  was 2.8    -   
m  s.  Lastly, the stability of both nanoparticles was assessed being evaluated the effect of 
temperature and storage time in particles sizes and PDI.  
Alginate, chitosan and zein are biodegradable, biocompatible, food-grade with good 
physicochemical properties and can be used in the development of biopolymer-based 
nanosystems. This work shows that these biopolymer-based nanosystems can be used for the 
encapsulation of water-soluble and liposoluble vitamins with a great potential for application in 
food products.  
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RESUMO 
As vitaminas são sensíveis e estáveis quando expostas a temperaturas inadequadas, oxigénio, 
luz e humidade. Para a indústria alimentar é importante reduzir algumas destas limitações e os 
nanosistemas aparecem como uma solução promissora. 
Este trabalho tem como principal objectivo o desenvolvimento e caracterização de nanosistemas 
para a encapsulação de (-)-riboflavina (vitamina hidrosolúvel) e ( )-α-tocoferol (vitamina 
liposolúvel) usando biopolímeros. Para a encapsulação da (-)-riboflavina foi usado o método pré-
gelificação ionotrópica, sendo o alginato e o quitosano os principais materiais. O ( )-α-tocoferol 
foi encapsulado através de automontagem da zeína, uma proteína do milho com carácter 
amfifílico.  
Inicialmente foi feito um estudo preliminar com o objectivo de determinar os parâmetros e 
concentrações óptimas dos biopolímeros e das vitaminas. Para o sistema do alginato e quitosano 
as concentrações óptimas foram 0,63 de alginato, 0,4 de quitosano e 0,065 mg/ml de (-)-
riboflavina. Para o sistama da zeína foram usados 2 e 1 mg/ml de zeína e ( )-α-tocoferol, 
respectivamente. Os nanosistemas foram caracterizados em termos de médias de tamanhos, 
índice de polidispersividade e potencial zeta (através de espalhamento dinâmico de luz) e 
eficiência de encapsulação da vitamina. A média dos tamanhos (por números) para as 
nanopartículas de alginato/quitosano com (-)-riboflavina foi de 110,17 (± 47,71) nm. O 
nanosistema apresenta valores de índice de polidispersividade e potencial zeta de 0,520 
(± 0,041) e -29,64 (± 0,97) mV, respectivamente. As nanopartículas de zeína com ( )-α-tocoferol 
apresentam uma média de tamanhos de 93,60 (± 1,09) nm e têm um índice de 
polidispersividade de 0,222 (± 0,020) com um potencial zeta de +26,08 (± 2,51) mV. Ambos os 
sistemas foram bem sucedidos na encapsulação das respectivas vitaminas, para a (-)-riboflavina 
os valores de eficiência de encapsulação (EE) e de capacidade de incorporação (LC) foram 
55,91 (  5,56) % e 2,18 (  0,63) %, respectivamente, e 94,95 (  4,17) % de EE e 
8,53 (  1,90) % de LC para o ( )-α-tocoferol. De forma a completar a caracterização de ambas 
as nanopartículas, também foram avaliados os perfis de libertação de ambas as vitaminas e 
foram calculados os coeficientes de difusão (D): para a (-)-riboflavina a 37 °C o D foi de 2,28 
    -   m  s para pH 7 e 4,95   0,74     -   m  s para pH 2 e a 25 °C o D foi de 
1,02     -   m  s e 1,88     -   m  s para pH 7 e 2, respectivamente; para o ( )-α-tocoferol 
encapsulado em nanopartículas de zeína a 37 °C pH 7 não houve libertação da vitamina e a 
pH 2 o D foi de 2,8    -   m  s. Por fim, a estabilidade de ambos os sistemas foi medida, 
sendo avaliados os efeitos da temperatura e do tempo de armazenamento nos tamanhos e PDI 
das nanopartículas. 
O alginato, quitosano e zeína são biodegradáveis, biocompatíveis, edíveis e com boas 
propriedades físico-químicas e estes podem ser usados no desenvolvimento de nanosistemas 
biopoliméricos. Este trabalho mostra que esses sistemas biopoliméricos podem ser usados para 
a encapsulação de vitaminas hidro- e liposolúveis com um grande potencial para aplicação em 
produtos na indústria alimentar. 
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1.1. THESIS MOTIVATION 
The food industry has as main challenges: to improve the production efficiency, food safety and 
food characteristics. This way, the maintenance and increase of chemical, physical, microbiologic 
and nutritional stability of food and compounds used in food is an essential aim to achieve.  
Vitamins have a special attention from food industry, because they have bioactive properties that 
are essential for normal maintenance, growth and development of human organism and their 
absence causes a specific deficiency syndrome. However, humans do not have the capacity to 
synthesize vitamins, except vitamin D and B3, meaning that they must obtain vitamins through 
ingestion of food (Ball, 2008; Combs Jr, 2012). The enrichment of food and/or beverages with 
vitamins is a good idea to complete a feed with absence of vitamins, but they can also be used to 
mask the flavor of vitamins and mineral or to improve taste of the food products. Nonetheless, 
vitamins are sensitive and unstable when exposed to inadequate temperature, oxygen, light and 
moisture. This way, the nanoencapsulation can be a solution to keep stability of vitamins (De 
Britto et al., 2012; Luo et al., 2012). 
Nanotechnology is an emergent and multidisciplinary field that is stimulating much interest 
across many areas of research and industries. This field involves the application, production and 
processing of materials with sizes at nano-scale and due to sizes of materials, the nanostructures 
when applied in food industry allow e.g. great improvements in bio-adhesive properties, 
appearance, texture, stability, or flavor of the product and release of bioactive compounds, higher 
bioavailability and can solve some problems such as compatibility and loss of activity of some  
functional compounds, affected by light, oxygen and temperature when dispersed in the food 
(Acosta, 2009; Kuan et al., 2012). In order to improve the efficiency and stability of 
nanostructures it is essential to find adequate materials; in the particular case of the food sector 
it is also important the replacement of non-food-grade materials by bio-based and biodegradable 
food-grade materials. Biopolymers, such as polysaccharides, proteins and lipids, open the door to 
new functionalities and applications due distinct advantages of biodegradability, edibility and lack 
of toxicity (Chassenieux et al., 2013).  
In doing so, the encapsulation of vitamins can solve the problems associated with used and 
incorporated of vitamins in food and/or beverages and can lead to an increase of stability and to 
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promote their bioactivity. It is possible that encapsulation of vitamins also improves the controlled 
release of vitamins in human digestive system. 
 
1.2. RESEARCH AIMS 
The main objective of this thesis was the development of nanosystems for the encapsulation of (-
)-riboflavin (water-soluble) and ( )-α-tocopherol (liposoluble) using biopolymer and their further 
characterization. The main focus areas were:  
i) The development and characterization of nanosystems; 
ii) Assessment of the intake of vitamins in nanosystems developed. 
 
1.3. THESIS OUTLINE 
The thesis is organized in five chapters, being this chapter the first and is described the 
motivation, research aims and outline of the thesis. The chapters 2 to 5 are distributed as 
follows: 
CHAPTER II - “INTRODUCTION”: Presents a review of the relevant literature about the theme of 
the thesis, being provide to the reader the basic information to understand the main issues of 
this work. 
CHAPTER III – “MATERIALS AND METHODS”: In this chapter is approached the materials and 
methodologies used for nanoparticles preparation and their characterization.  
CHAPTER IV – “RESULTS AND DISCUSSION”: Shows all results and their discussion. In this 
work was development two nanosystems with different characteristics, so this chapter has two 
main titles: “ALGINATE CHITOSAN NANOPARTICLES” and “ZEIN NANOPARTICLES”. 
CHAPTER V – “GENERAL CONCLUSIONS”: Presents the overall conclusions and 
recommendations and suggestions for future work. 
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2.1 NANOTECHNOLOGY 
On 29 December 1959 the physicist Richard Feynman (Nobel Prize for Physics 1965) gave a 
speech entitled “There’s Plenty of Room at the Bottom” in annual meeting of the American 
Physical Society at the California Institute of Technology and proposed the exploration of 
materials at scale of atoms and molecules resulting in something that human wouldn’t see 
(Asiyanbola and Soboyejo, 2008; Miyazaki and Islam, 2007). This way began the history of 
nanotechnology. However, just in 1974 the nanotechnology term was first used and defined by 
Norio Taniguchi (researcher of University of Sciences in Tokyo) to refer the processing, 
separation, consolidation and deformation of materials at scale of an atom or a molecule 
(Asiyanbola and Soboyejo, 2008; Kuan et al., 2012; Miyazaki and Islam, 2007). Currently, the 
nanotechnology is defined as a science that involves the design, synthesis, characterization and 
application of materials at the nano-scale, being one nanometer (nm) one-billionth of a meter 
(Calster, 2006; Commission, 2004; Kuan et al., 2012). Generally, all particles with a size less 1 
micrometer (µm) are classified as nanoparticles (Asiyanbola and Soboyejo, 2008; Mohanraj and 
Chen, 2006), but different interpretations of the nanoparticle dimensions have been proposed 
and the more stringent classifications for nanoparticle just include particles with a size in the 
range of 1-100 nm (Calster, 2006; Cushen et al., 2012; Reverchon and Adami, 2006). These 
stringent classifications are justified by the fact that some physical properties appear when the 
materials reach the values 1-100 nm, but the legitimate definition classifies the sub-micron scale 
as nano and extends the limit to 1 µm (Buzea et al., 2007; Naahidi et al., 2013). 
The materials at nano-scale change their physics, chemistry and biologic properties and these 
changes are due to increase of relative surface and quantum effects that begins to control the 
material at this scale. This way, the utilization of nanomaterials, when compared with normal 
utilization (micro or macro), is an added advantaged because they can have better properties 
such as: increased physical strength, chemical reactivity, electrical conductivity, magnetism and 
optical effects (Buzea et al., 2007; Chau et al., 2007; Siegrist et al., 2008). As result, nowadays, 
exist ever more technological sectors, e.g. medical, information technologies, energy production 
and storage, materials science, manufacturing, instrumentation, food, water and environmental 
and security, that betting on nanotechnology a way to achieve better results for various problems 
and to create new technologies. In doing so, the investments in nanomaterials research have 
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increased, making the nanotechnology an expanding technology with many applications 
(Commission, 2004; Miyazaki and Islam, 2007; Pitkethly, 2004). 
Nanotechnology can help the food sector achieving some of its main goals, i.e. improve 
production efficiency, increase food safety and enhance food characteristics; to do that 
applications in food industry are focused on the development of nano-size delivery systems for 
functional ingredients and additives, and innovative packaging. Actually, food sector is one of the 
sectors with fewer applications at nano-scale, but it is expected that in the near future the 
nanomaterials in food industry increase (Cushen et al., 2012; Weiss et al., 2006). This increase 
can be explained by advantages related with the size reduction of materials e. g. improvement of 
bio-adhesive properties, that includes an increase of adhesive force and prolonged 
gastrointestinal transit time, possible leading to a higher bioavailability (Acosta, 2009). Based on 
these unique characteristics nanosytems can solve some problems occurring when using 
systems at macro- and microscale for delivery of functional compounds; such problems are: 
compatibility (e.g. aggregation and phase separation) with the food matrix (influencing e.g. 
appearance, texture, stability, or flavor of the product); release, that should be controlled and only 
activated once inside the human gut (i.e. some compounds start to be released when mixed with 
the food product and functional compounds lose their activity); and loss of activity of some 
functional compounds, affected by light, oxygen and temperature when dispersed in the food 
matrix. This versatility and limitless potential of nanotechnology allow its application in different 
systems that are part of food sector (Figure 2.1). 
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2.2 EDIBLE AND BIO-BASED MATERIALS 
The technological sectors that use nanotechnology have a greatest challenge: to find materials 
that ensure the efficiency and stability of nanosystems; and in the food sector is also important 
replacement of non-food-grade materials by bio-based and biodegradable food-grade materials. 
In food sector, the physic-chemical properties, such as solubility, molecular weight, glass/melting 
transition, crytallinity, diffusivity, film forming and emulsifying properties, or costs of material are 
important factors in materials selection (Sagalowicz and Leser, 2010). Besides that, it is also 
necessary to take account the future characteristics of nanosystems, e.g. size, morphology, 
biodegradability, biocompatibility, cytotoxicity, drug loading, release profile and preparation 
method (Matalanis et al., 2011; Sundar et al., 2010). Initially, the synthetic polymers were the 
basis of nanosystems, because they have great properties of durability and strength. However, 
the use of synthetic polymers triggered a lot of environment and health problems, because they 
are produced from fossil fuels, are not biodegradable and the synthesis of some polymeric 
materials involves the use of toxic compounds or generation of toxic products. So, it is important 
to use renewable source-based biopolymers materials of natural origin that not involve the use of 
Product 
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Figure 2.1 - Applications of nanotechnology in food sector. Image adapted from Blasco and Picó (2011) 
and Weiss et al. (2006). 
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toxic or harmful components in their development, use or degradation (U.S. Congress 1993; 
Wang et al., 2005).  
Biopolymers are polymers produced by biological systems (e.g. microorganisms, plants and 
animal) or using chemical processes derived from biological starting materials such as amino 
acids, sugars, natural fats or oils. They are mainly composed by repeating units of saccharides, 
amino acids, lipids, peptides and nucleic acids, Figure 2.2, and have the characteristic of being 
degraded by biological activities (Chassenieux et al., 2013; Kuan et al., 2012; U.S. Congress, 
1993). Polysaccharides (e.g. alginate, pectin, dextran and chitosan), proteins (e.g. zein, whey 
protein isolate) and lipids (e.g. medium chain triglycerides, tristearin and corn oil) are some 
examples of biopolymers. The utilization of biopolymers open  the  door  to  new  functionalities  
and applications due distinct advantages of biodegradability, edibility  and  lack  of  toxicity 
(Chassenieux et al., 2013). 
 
  
 
 
 
 
 
 
 
´ 
 
2.2.1 POLYSACCHARIDES 
Polysaccharides are natural polymers composed by simple sugars (monosaccharide residues) 
that are linked by different glucosidic bonds (U.S. Congress, 1993; Yang and Zhang, 2009). The 
Figure 2.2 – Some basic structure of polymers. Image adapted from U. S. Congress (1993). 
Monomer 
Repeat Unit (Formed when different units are linked 
together) 
Linear homopolymer 
Linear copolymer 
Branched homopolymer 
Chemical bonds 
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polysaccharides are present in plants, fungi, bacteria, algae and animals, and the source/origin 
(environmental conditions and history) and their monomer sequence can be responsible for the 
molecular structure of polysaccharides (Matalanis et al., 2011; Yang and Zhang, 2009). Each 
polysaccharide has different chemical structures (e.g. type, number, sequence and bonding of 
the monosaccharide within the polymer chain), which are responsible by molecular weight, 
degree of branching, structure, flexibility, electrical charge and interaction between 
polysaccharides. Besides, depending of the ionic groups presented in the polysaccharide chain, 
some polysaccharides can be neutral (e.g. starch and cellulose), anionic (e.g. alginate, 
carrageenan, xanthan and gum Arabic), or cationic (e.g. chitosan). This differences allow to 
polysaccharides present different functional properties such as: solubility, thickening, gelation, 
water holding capacity, surface activity, emulsification and digestibility (Yang and Zhang, 2009). 
Based on the existing great variety of polysaccharides it is necessary when choosing one or more 
polysaccharides for bio-based nanosystems preparation to considerer their physicochemical 
properties and the desired characteristics of the bio-based nanosystems (e.g. morphology, 
density, refractive index, size, charge and stability) (U.S. Congress, 1993; Yang and Zhang, 
2009). 
For the presented work two polysaccharides (alginate and chitosan) were used as material for the 
development of bio-based nanosystem. Below, are presented the most important characteristics 
of these two polysaccharides. 
 
2.2.1.1 Alginate 
Alginate is an hydrophilic polysaccharide extracted from marine brown algae of the Phaeophyta 
family. It is a linear biopolymer composed by two uronic acids, 1,4-linked-ȕ-D-mannuronic acid 
(M) and α-L-guluronic acid (G), being carboxylic groups from uronic acids responsible by their 
negative charge (Figure 2.3).  Alginate is considered a non-toxic, biocompatible, biodegradable 
and mucoadhesive polysaccharide  (Silva et al., 2006; Sundar et al., 2010; Vrignaud et al., 
2011) and it approved for application in pharmaceutical and food industry.  
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Figure 2.3 – Chemical structure of alginate. The monomeric units of alginate, 1,4-linked-ȕ-D-mannuronic 
acid (M) and α-L-guluronic acid (G), can be linked in varying sequences, as blocks of alternating gulutonic 
and mannuronic residues, blocks of guluronic acids and of mannuronic acids (Sundar et al., 2010). Image 
from Vrignaud et al. (2011). 
 
The solubility of alginate in water depends on the associated cations, for example sodium 
alginate is soluble in water but when a solution with multivalent cations (e.g. calcium - Ca2+) is 
used the biopolymer can form a reversible gel (Sarmento et al., 2007; Silva et al., 2006; Sundar 
et al., 2010). The gelling property of alginate is promoted by the high selectivity of guluronic acid 
residues that in the presence Ca2+ organized in side-by-side blocks formatting the so called “egg 
box” model. The arrangement is due to an electrostatic interaction between Ca2+ and the 
negatively charged oxygen atoms (Figure 2.4). The gelling property of alginate depends of 
following factors: sequential order and composition of mannuronic and guluronic acid residues, 
molecular weight of biopolymer and concentration of counter ions in solution (Sarmento et al., 
2007; Silva et al., 2006). However, the addition of a polyelectrolyte complex such as chitosan or 
poly-L-lysine induces a polyelectrolyte complex formation and stabilization of the alginate pre-gel 
nucleus into individual sponge-like particles (Sarmento et al., 2007). The hydrophilic and gelling 
properties, make of alginate a biopolymer with a considerable potential for encapsulation of 
hydrophilic components (Vrignaud et al., 2011).  
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Figure 2.4 – (a) Binding of cation Ca2+ and guluronic acid residue of alginate; (b) “Egg box” model. Image 
adapted from Chavanpatil et al. (2007) and Myrvold and Onsoyen (2004). 
 
2.2.1.2 Chitosan 
Chitosan is a cationic polysaccharide derived from the N-deacetylation of chitin, the second most 
abundant natural biopolymer. The chitin is obtained from exoskeletons of marine arthropods (e.g. 
shells of crabs, shrimps and krill), walls of fungi (e.g. fungal mycelia) and cuticle of insects. It is a 
linear cationic copolymer composed by N-acetylglucosamine and glucosamine residues with ȕ-
1,4-linkage (Mourya and Inamdar, 2008; Shahidi et al., 1999; Sundar et al., 2010). Chitin has 
unique properties such as ability to polyoxysalt formation, chelate metal ions and optical 
structural characteristics. However, it is insoluble in water and in most organic solvents, being its 
biodegradation very slow. So, chitosan, chitin deacetylated form, appears as a great solution for 
these solve that problems (Kumar, 2000; Shahidi et al., 1999). 
Chitosan is a linear copolymer composed by repeating units of 2-amino-2-deoxy-ȕ-D-glucan with 
glycosidic linkages, where the amine groups confer of chitosan special properties (e.g. high 
charge density, readily available for chemical reactions and salt formation with salts) (Agnihotri et 
al., 2004; Sundar et al., 2010). Chitosan present three types of reactive functional groups: an 
amino group as well as both primary and secondary hydroxyl groups at the C-2, C-3 and C-6 
position, respectively (Shahidi et al., 1999). The position of free amino and N-acetyl groups is 
responsible by solubility of chitosan; nevertheless, the chitosan solubility is improved with organic 
solvents as aqueous acids (e.g. formic acid and acetic acid) (Agnihotri et al., 2004; Kumar, 
2000; Mourya and Inamdar, 2008). The increase of solubility is due to protonation of amino 
groups by acids that along the chitosan chain increase the polarity and the degree of electrostatic 
repulsion (Mourya and Inamdar, 2008). N-deacetylation of chitin during chitosan formation is not 
complete, and chitosan can have a degree of deacetylation between 40-98% (Mourya and 
   Ca2+ 
(a) (b) 
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Inamdar, 2008) and molecular weight ranged between 3.8 and 2000 KDa; these two 
characteristics can influence chitosan properties being important factors for its use in several 
applications  (Mourya and Inamdar, 2008; Sundar et al., 2010).   
This biopolymer has great properties such as biocompatibility, biodegradability, non-toxicity, and 
several studies indicated chitosan with a great adsorption and muchoadhesive properties, 
antifungal activity, ability to promote metabolic changes, an excellent film-forming ability and 
micro/nanoparticles developing. Due to these properties, the chitosan have a great potential for 
food, environmental, pharmaceutical, medical and agriculture sectors (Agnihotri et al., 2004; 
Kumar, 2000; Peniche and Acosta, 2003; Sarmento et al., 2007; Sundar et al., 2010; Weber, 
2000).  
 
 
 
 
 
Figure 2.5 – Chemical structure of chitosan. Image adapted from Kumar (2000) and Mourya and Inamdar 
(2008). 
  
2.2.2 PROTEINS 
Proteins are biopolymers that are present in plants (e.g. zein, gluten and soy) or animals (e.g. 
casein, whey, collagen and keratin) composed by a linear sequence of amino acids linked by 
peptide bonds; exist 20 amino acids and many different combinations and sequences, so the 
proteins can have distinct structures and properties (Weber, 2000; Nelson and Cox, 2000).  
Amino acids are composed by a carboxyl group (COOH) and an amino group (NH3) linked to a 
carbon atom. Besides that, they have a side chain, R group, which varies in structure, size and 
electrical charge for each amino acid being responsible for their solubility and polarity. Taking 
into account properties of R group, the amino acids can be classified as aromatic, nonpolar or 
polar and uncharged or positively or negatively charged (Nelson and Cox, 2000).  The amino 
Primary amino function 
Secundary hydroxy function 
Primary hydroxy function 
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acids bind to each other by amide linkages between the amino group of one amino acid and the 
carboxyl group of another by removal of the elements of water, these linkages are called of 
peptide bonds. Polypeptide is the product of linkages between two or more amino acids and have 
a low molecular weight, when the linkages contain more than 50 amino acids presenting a higher 
molecular weight (ranged between 6/10 and 40 000 KDa), they are called of protein (McKee and 
Mckee, 2013; Wade, 2012). 
Proteins have a great range of structural and catalytic properties, being their amino acids 
sequence, environmental conditions and the physico-chemical treatment (e.g. exposure to 
different temperatures, pressures, solvents, pH values and ionic composition) responsible for it. 
As a result of their diversity/complexity, they can be classified according to chemical 
composition, shape, structure or function as shown in Figure 2.6 (McKee and Mckee, 2013; 
Wade 2012; Nelson and Cox, 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 – Classification of proteins and their characteristics. 
Classification of Proteins 
Chemical 
Composition 
 
Shape Structure Function 
Simple  
(Contain only amino 
acids) 
 
Conjugated 
(Proteins conjugated 
with non-proteins) 
Fibrous 
(Long and rod-shaped 
molecules) 
 
Globular 
(Compact spherical) 
 
Random coil 
Primary 
(Simple chain of amino acids) 
 
Secondary 
(Refers to stable arrangements 
of amino acids based, 
especially, on hydrogen 
bonded) 
 
Tertiary 
(Proteins with three-
dimensional shape) 
 
Quaternary 
(Protein has two or more 
polypeptides chains (or 
subunits)) 
Catalysis 
 
Structure support 
 
Cell movement 
 
Defense 
 
Regulation  
 
Transport 
 
Storage  
 
Stress response 
CHAPTER II 
INTRODUCTION 
 
16 | DEVELOPMENT OF NANOSTRUCTURES FOR ENCAPSULATION OF VITAMINS  
 
The proteins not only have a great biochemical interest, but also, due to their functional 
properties, such as self-assembly, emulsification, gelation, foaming, water binding capacity and 
gas barrier, have a big potential as technological biomaterial (Chassenieux et al., 2013; Chen et 
al., 2006; Weber, 2000). For example, in food sector, they can be used to produce biopolymer-
based delivery systems or film forming solutions for packaging materials being these systems 
relative easy to prepare, biodegradable, immunogenic, nontoxic and present a greater stability in 
vivo and during storage (Sundar et al., 2010). However, different factors must be considered 
when proteins are chosen as biomaterial and is important to: a) establish appropriate 
physicochemical conditions for protein associate with other proteins or non-proteins; b) establish 
the electrical characteristics between the involved molecules when electrostatic interactions are 
used to structure formation; c) know the properties of biopolymer particles formed after protein 
association (e.g. morphology, physical properties, size, charge and stability) (Matalanis et al., 
2011).  
Due to the potential of proteins as bio-based material zein was used for nanostructure 
preparation. Below are presented the most important characteristics and the reason for this 
choice. 
 
2.2.2.1 Zein 
Corn or maize (Zea mays) is one of the most important cereals on food industry and their main 
components are starch, proteins and water. The proteins represent one of the greatest 
components and about 75 % are present in endosperm tissue, being zein the major storage 
protein of corn (Lawton, 2002; Shukla and Cheryan, 2001).  
Zein was first isolated in 1821 by John Gorham and was described as a soft, ductile, tenacious 
and elastic protein, but only in 1939 began the commercial production due their deficiency in 
essential amino acids (e. g. lysine and tryptophan) and insolubility in water. However, since its 
isolation in 1821, zein has scientific interest as a polymeric material and their properties such as 
ability to form tough, glossy, hydrophobic grease-proof coatings and their resistance to microbial 
attack has been explored (Lawton, 2002; Shukla and Cheryan, 2001). Zein is also biodegradable 
and renewable and is one of the few cereal proteins that are extracted in relatively pure form. So, 
zein is considered as safe and food grade ingredient with a great potential for: film, coatings and 
plastics applications, encapsulation and controlled release of fat-soluble compounds and for that 
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can be used in food and pharmaceutical sector (Lawton, 2002; Luo et al., 2011; Shukla and 
Cheryan, 2001; Weber, 2000).  
Zein is considered a prolamin and is amphiphilic due their structure containing three quarter of 
lipophilic and one quarter of hydrophilic amino acids residues (Luo et al., 2011). The 
composition of amino acids sequence is responsible for its solubility: zein is insoluble in water 
except in the present of alcohol such as ethanol and isopropanol, or in the presence of high 
concentrations of urea or alkali and anionic detergents (Lawton, 2002; Shukla and Cheryan, 
2001). It has a surface charged that varies according to the pH of environment (Deo et al., 
2003). During zein extraction from corn is used a suitable solvents and as a result is obtained a 
native form of protein in heterogeneous mixture of disulfide-linked aggregates with a molecular 
weight of 44 000 Da (Shukla and Cheryan, 2001). This protein is composed by a mixture of four 
distinct types of peptides that varying in molecular size, solubility and charge and can be 
separated using their different solubility. The four peptides are denominated as α-, Ȗ-, ȕ- and δ-
zein, being α- and Ȗ-zein the most abundant types (Lawton, 2002; Shukla and Cheryan, 2001). 
Exist three models for structure of zein (Shukla and Cheryan, 2001; Wang and Padua, 2012a): a) 
helical wheel model for zein where antiparallel helices are clustered within a distorted cylinder 
stabilized by hydrogen bonds (Argos et al. 1982); b) model where helices are linked by 
glutamine-rich bridges that are aligned in an antiparallel fashion (Matsushima et al. 1998); c) a 
three-dimensional structure, being a coiled-coil super helix with lutein at the core (Momany et al. 
2006) (Figure 2.7). 
 
Figure 2.7 – Structure models of zein: (a) Argo’s model; (b) Matsushima’s model; (c) Momany model. 
Image (a) and (b) adapted from Y. Wang and Padua (2012) and (c) adapted from Momany et al. (2006). 
(a) (b) 
(c) 
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Top down Bottom up 
2.3 NANOSYSTEMS IN FOOD SECTOR: PREPARATION AND CHARACTERIZATION 
In general, the selection of materials to prepare nanosystems is very important and a great 
challenge, but the nanosystem and their characteristics are one of the most important factors to 
ensure the efficiency and stability of nanosystem selected.  
Nanosystems can be classified based on ( Morris 2010; Silva et al. 2011):   
-  the major material used in their fabrication;  
-  the production method (e.g. bottom-up or top-down);   
-  the predominant forces in the system (e.g. electrostatic, hydrogen bonding);   
-  the main properties of the system (e.g. mechanical and optical properties) and  
-  the system’s overall free energy (thermodynamic or kinetic stable systems).  
One of the major trends in the development of nanosystems is to combine different approaches 
such as: mixtures of the materials used, combination of bottom-up strategies (nanosystems are 
obtained by interaction of small components such as layer-by-layer and self-assembly) and top 
down strategies (formation of nanosystems by physical-chemical processes that involve reduction 
of particle size to nano-size, e.g. homogenization), and intervention of different types of forces 
during the production process (Choi et al., 2011; Hu et al., 2007; Lertsutthiwong et al., 2008; Yu 
et al., 2006) in order to achieve a desired functionality. In the last years a large number of 
different delivery nanosystems have been developed, often using a trial-and-error approach, 
which leads to a great number of developed and well characterized nanosystems however 
without a final and conclusive application.  
 
 
 
 
 
In the food sector, the utilization of delivery systems, in particularly, at the nano scale showed to 
be promising as active vectors. Some of the reasons are their capacity to release bioactive 
compounds and their high intracellular uptake. Their capacity to improve the stability of active 
substance and their high encapsulation efficiency (Mora-Huertas et al., 2010).  
Figure 2.8 – Top down and bottom up approaches. Image adapted from Reverchon and Adami (2006). 
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2.3.1 NANOCAPSULES 
Nanocapsules, also called nanoparticles, are constituted by an external cavity consisting of a 
polymeric membrane and an internal part composed by a liquid or polymeric matrix that  
contains the active compound (Fang and Bhandari, 2010; Mora-Huertas et al., 2010). The 
selection of an appropriate method for nanocapsules production is an important step in order to 
have nanostructures with properties allowing the desired performance and functionality. The 
method will depends on the physicochemical character of the polymer, the bioactive compound, 
the final application and the desired properties for the nanocapsules (e.g. particle size, particle 
size distribution, surface area, shape, solubility, encapsulation efficiency and release mechanism) 
(Ezhilarasi et al., 2013; Pal et al., 2011; Rao and Geckeler, 2011). The methods for preparation 
of nanocapsules are divided in three main techniques: polymerization (preparation of 
nanocapsules through polymerization of monomers using classical polymerization or 
polyreactions), dispersion of preformed polymers (nanocapsules are obtained directly preformed 
from synthetic, semi-synthetic or natural polymers) and ionotropic pre-gelation/coacervation 
(Pinto Reis et al., 2006; Rao and Geckeler, 2011). During and after nanocapsules formation is 
important their characterization and in order to evaluate main characteristics. For that is 
commonly used two types of methods: characterization methods (e.g. measurement of size, 
morphology, charge and stability) and chemical composition methods (Blasco and Picó, 2011).  
 
2.3.1.1 Preparation Methods 
Ionotropic pre-gelation/coacervation  
Ionotropic pre-gelation/coacervation methods are based on the ability of polyelectrolites to cross-
link in the presence of a counter-ion (Patil et al., 2010) being commonly used biodegradable 
hydrophilic polymers (e.g. chitosan, sodium alginate and gelatin) to form nanocapsules 
(Mohanraj and Chen, 2006). Ionotropic pre-gelation/coacervation involves the blend of a 
polymer, with positive or negative charge, and a cationic counter-ion (e.g. calcium chloride) or 
polyanionic (e.g. sodium tripolyphosphate). Then a second polymer is added that allows 
polyelectrolyte complexation and nanocapsules formation. The bioactive compound is entrapped 
in the core of the first polymer and stabilized after the addition of the second polymer. The 
polyelectrolyte solutions and bioactive compound are added in a counter-ion solution or vice-versa 
drop wise with a needle under magnetic stirring (Calvo et al., 1997; Sarmento et al., 2007). This 
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methodology is based in physical-chemical mechanisms; therefore it is affected by several 
parameters such as stirring, flow rate of solutions, polymers characteristics (e.g. molar mass, 
flexibility and charge), pH, ionic strength, concentration and polymers ratio (Ezhilarasi et al., 
2013). The nanocapsules produced by this method can be used, for example, to encapsulation 
of riboflavin, curcumin, tea catechins and capsaicin (Das et al., 2010; Hu et al., 2007; Wang et 
al., 2008).  
 
 
 
 
 
 
 
 
  
 
 
 
Self-assembly 
The self-assembly process uses polymers with capacity to form spontaneously compact and 
stable nanocapsules. One of the main driving forces for self-assembly is amphiphilicity and some 
weak interactions such as van der waals, capillary, π-π and hydrogen bonds. Besides that, it is 
also important to exist a long-range repulsion, for example, thermodynamic incompatibility, phase 
separation, excluded volume and columbic repulsion, between the polymers and the medium. 
Thus, this method consists in a polymer structure organization without help or guidance from 
external agents (Reches and Gazit, 2006; Sanguansri and Augustin, 2006; Wang and Padua, 
2012a). The nanocapsules formed by self-assembly are dependent on the size and shape of 
polymer, composition of solution and environmental stresses. Materials such as zein, casein, 
Figure 2.9 – (a) Schematic of Ionic pre-gelation/coacervation method; (b) Structure of nanoparticle with 
bioactive component loaded: Bioactive component; Chitosan;  Alginate. Images 
adapted from (a) Nagavarma et al. (2012) and (b) Y. Zhang et al. (2011) and Mora-Huertas et al. (2010). 
Addition of a counter ion 
solution (e.g. CaCl2)  
Solution of biopolymer 
with positive or negative 
charge (e.g. Alginate) 
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loaded nanoparticles 
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(b) 
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chitosan and polylactic acid are examples of polymers used in the production of nanocapsules by 
this method. Typically, nanocapsules have an average size of 50-100 nm (Sanguansri and 
Augustin, 2006). Some works show that this process is able to produce nanocapsules that can 
be utilized in food industry e.g. in the encapsulation of vitamins (Li et al., 2011). 
 
2.3.1.2 Characterization Methods 
Dynamic Light Scattering (DLS) 
Dynamic Light Scattering (DLS) or also known as Photon Correlation Spectroscopy (PCS) or 
Quasi-Elastic Light Scattering (QLS) is a not invasive, versatile and useful set of techniques to 
measure the particle size, polydispersity index (PDI), zeta potential and (in some cases) the 
shapes of particles with a size down to 1µm in solution. Normally, this technique is used in the 
characterization of emulsions, micelles, polymers, proteins, nanoparticles or colloids (Malvern 
Instruments, 2004; Pecora, 2000).  
The particle size is the diameter of nanoparticles and the polydispersity index (PDI) is parameter 
that gave us the distribution of nanoparticles size. The PDI is dimensionless and values greater 
than 0.2 indicate that the sample is not monodisperse, in other words, has a very broad size 
distribution. The measurements of these parameters are based in a simple principle: illuminating 
of sample with a laser and analyzing the scattered light, where the detector position can be at 
either 173° or 90° depending on the model of Zetasizer Nano model. Due to different sizes of 
particles, the light are scattered in different directions and with different intensities, being 
monitored the scattered light intensity (particle size) and Brownian motion (random movement of 
particles carrying on the time - the large particles have a slow moving and small particles have a 
quick). The relationship between these parameters (movement and size of particles) allow to 
determine the diameter of particles using the Stokes Einstein equation, Eq. 2.1 (Dahneke, 1983; 
Goldburg, 1999; Malvern Instruments, 2004).  
 
d (H)     T3 π   D 
Eq. 2.1 
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Hydrodynamic diameter, d (H);  
Boltzmann’s constant ( ); 
Absolute temperature (T); 
Viscosity ( ); 
Translational diffusion coefficient (D). 
 
The average size (z-average diameter) estimated by DLS is obtained through an intensity 
distribution, but these results can be converted in a volume distribution that can also be 
converted to a number distribution (Malvern Instruments, 2004).   
The Zeta Potential (ζ) is other parameter that can be measurement by DLS and consist, 
essentially, in measurement of electrostatic/charge at the surface of the nanoparticle through a 
laser that passes the sample cell. The scattering is detected at an angle of 90°. This 
measurement can give information related with dispersion, aggregation or flocculation of 
dispersions, emulsions and suspensions (Kirby and Hasselbrink, 2004; Malvern Instruments, 
2004).  
 
Nanoparticle Tracking Analysis (NTA) 
The NTA is a recent and innovative technique that combines a laser light scattering microscopy 
with a charge-coupled device camera. So, is possible the visualization and recording of particles 
in a solution. NTA determines particle size and measures the concentration of particles with size 
ranged from 30 to 1000 nm. These measurements are possible due the capacity equipment to 
identify and track the particles through Brownian motion than then are used in a expression 
derived of Stokes-Einstein equation for particle size calculation. For the measurement of particles 
concentration is calculated the scattering volume through dimensions of field of view and the 
depth of the laser beam, then scattering volume calculated is extrapolated and is determined the 
average of concentration (number of particles per milliliter of sample). Furthermore, the scattered 
light is captured by a charge-coupled device camera, being obtained an image and recorded  a 
video of the particles of sample  (Filipe et al., 2010; Gillespie et al., 2011). 
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Transmission Electron Microscopy (TEM) 
TEM is a conventional microscopy technique based in transmission of electron and is considered 
the most powerful of microscopes. The aim of this technique is to provide information about 
morphologic, compositional and crystallographic of samples. In general, the TEM has an electron 
source, thermionic gun, electron beam, electromagnetic lenses, vacuum chamber, condensers, 
sample stage, phosphor or fluorescence and a computer (Reimer, 1984; Wang, 2000).  
TEM images with present high-resolution and are two dimensional, being obtained through an 
electron interaction whit sample. In generally, an electron beam is emitted and will be propagate 
along different directions, when this electron beam interacts with sample that are present in TEM 
grids can happen three different interactions: unscattered electrons – transmitted beam, 
elastically scattered electrons – diffracted beam and inelastically scattered electrons. The 
contrast of image depend of the amount of sample that electron beam pass and the sample 
material, being a good image when a contrast of sample is greater relative to the background. 
Due to their advantages (e.g. high-quality and detailed images, can provide information about 
surface, shape, size, compounds and structure of particles), this technique is used in different 
fields, such as nanotechnology, medical, biological, life sciences and industrial fields (Reimer, 
1984; Voutou and Stefanaki, 2008).  
 
Release Profile 
The release profile of a bioactive compound is equally important as the bioactive polymer 
formulation because to understand the release profile can be crucial for product development 
and potential applications (Kumari et al., 2010; Pinheiro et al., 2012a, 2012b). Commonly, the 
release profile is also determined as an alternative to characterize nanoparticles, along with 
others parameters (e.g. particle shape, size, zeta-potential and encapsulation efficiency) (Zambito 
et al., 2012). 
A method used to evaluate the release profile is dialysis membrane and this method consists, 
essentially, in to separate the nanoparticles with bioactive compound loaded from the bulk media 
by a dialyzing membrane, Figure 2.10. Over the time, occurs the passage of compound loaded in 
nanoparticles through the membrane into the release media and a sample is withdrawn at 
intermittent intervals to evaluate the compound release (Souza and Deluca, 2005).  
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There are four mechanisms that can be responsible by release profile of bioactive compound 
from nanoparticles: Mechanism of Fic ’s diffusion, polymer matrix swelling, polymer erosion and 
degradation; and the different mechanisms depending on the system and environmental 
conditions. However, to understand the release mechanism involved is necessary to use 
mathematical modeling (Pinheiro et al., 2012b). The release profile depends of various 
parameters, such as value of diffusion coefficient, size and shape of bioactive compound and 
polarity of the matrix (Romero-cano and Vincent, 2002).  
 
2.4 BIOACTIVE FOOD COMPOUNDS 
The normal development and growth of human depend of different constituents, being one of 
them bioactive compounds. These components are substances/compounds present in animal 
and plants that can have different physiological functions, such as health promoting or disease 
preventing effect (De Vos et al., 2010). Each bioactive component has their own molecular 
characteristics (e.g. molecular weights, conformations, polarity and charge) that are responsible 
by physicochemical differences between bioactive components (e.g. solubility, partitioning, 
physical state, interactions, optical characteristics and chemical stability). They can be divided 
into bioactive molecules such as vitamins, bioactive peptides, antioxidants, fatty acids and 
minerals; and bioactive living cell such as probiotics (McClements et al., 2009; de Vos et al., 
2010), which can be used in food industry to improve taste, aroma, stability, nutritional value 
and appearance of fodd products (Augustin and Hemar, 2009; Raybaudi-Massilia and Mosqueda-
Melgar, 2012). Some of these bioactive compounds are sensitive to heat, moisture and/or pH 
and can be slowly degraded and lose their activity during utilization. This way, the food industry 
has a great challenge: protect these components during production, storage and consumption. 
Sealable Cap 
Dialysis Membrane 
Nanoparticles Release media 
Magnetic stir bar 
Figure 2.10 – Schematic presentation of set-up for release profile by dialysis membrane method. Image 
adapted from Prata et al. (2008) and Souza and Deluca (2005). 
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The micro- and nanoencapsulation with edible materials appears as a solution to overcome these 
problems, in order to protect the bioactive compound against adverse conditions and 
simultaneous keep the functionality of the bioactive compound. Due to their different properties, 
is needed to develop micro- or nanostructurs with specific physicochemical characteristics to 
promote compatibility and stability between bioactives compounds and the structure used. 
Besides that, it is also essential to select a system easily incorporated into the food and that does 
not interfere with the texture and taste of the food (De Vos et al., 2010). 
As already mentioned the vitamins are an example of bioactive component that plants and 
microorganisms have the capability to produce for the normal organism functioning. The human 
haven’t this ability, but it is recognized that vitamins are essential for maintain health and well-
being of human (Spitzer and Schweigert, 2007). Below are presented the most important 
characteristics of them and their importance for us. 
 
2.4.1 VITAMINS 
In nineteenth century, the physiologists thought that food was a source of only four types of 
nutrients (protein, fat, carbohydrate and ash) and water, being vitamin only associated with the 
preventing of vitamin disease and their biochemical functions. Today, this opinion is different and 
the term vitamin is a common word that reveals an interrelationship between diet/food and 
health (Combs Jr, 2012).  
Vitamins are defined as organic molecules with small dimension and low molecular weight being 
presented in food in small amounts. They are considered essential for normal maintenance, 
growth and development of human organism and their absence cause a specific deficiency 
syndrome. The incapacity of human to synthetize some vitamins (exception of vitamin D and B3) 
lead to their necessity to get through food products (Ball, 2008; Combs Jr, 2012).  In general, 
the pathway of vitamins biosynthesis is complex and is biologically more efficient for human to 
ingest the vitamins that synthetize through simples’ molecules. This fact has a disadvantage that 
is the dependency of the other organisms to get essentials components to life (Berg et al., 2004).  
In general, all vitamins have similar characteristics, but their chemical properties are very 
different (e.g. the vitamins A, K and C are enzymatic co-factors, E and C act as antioxidants and 
vitamins A and D are hormones). Besides that, vitamins can be divided into liposoluble and water 
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soluble vitamins according their solubility in water (Combs Jr 2012; Berg, Tymoczko and Stryer 
2004). As other bioactive components, the vitamins are also sensitive and unstable when 
exposed to inadequate temperature, oxygen, light and moisture. So, the micro- or 
nanoencapsulation can help to reduce these limitations and to provide a prolonged shelf life and 
stability. The encapsulation of vitamins can also use as nutritional supplements, to mask the 
flavor of vitamins and mineral or to improve taste of the food products (De Britto et al., 2012).  
 
2.4.1.1 Riboflavin (Vitamin B2) 
The vitamins of complex B (B1, B2, B3, B5, B6, B8, B9 and B12), vitamin C, H and pantothenic 
acid are soluble in water, being classified as water-soluble vitamins. The vitamin B2 is a flavin 
and was first isolated in 1933 from egg. Initially, was called ovoflavin, but when was determined 
their chemical structure was called riboflavin because molecule contained a ribose-like structure 
(ribitol). Their molecule also contain an isoalloxazine tricyclic ring and methyl groups (Figure 
2.11) and are present in all animal and plants cell being the most common sources of riboflavin 
wheat bran, milk and milk products, eggs, meats and vegetables (Ball, 2008; Sebrell Jr and 
Harris, 1954).  
 
 
 
 
 
Figure 2.11 – The Chemical structure of riboflavin.  
Image from http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6759 (September 19, 2013). 
 
The riboflavin is a precursor of coenzymes flavin mononucleotide (FMN) and flavin adenine 
dinucleotide (FAD) that act as electron carriers in oxidation-reduction reactions. These coenzymes 
are called flavoproteins and are essential for hundreds of enzymes FMN- and FDA-dependents, 
amino acids metabolism, energy production and activation of folate and pyridoxine coenzymes. 
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The absence of riboflavin has been linked to cancer appearance, cardiovascular disease, anemia 
and neurological and developmental disorders  (Burgess et al., 2009; Roje, 2007). 
Relatively of riboflavin stability, is known that this vitamin lose 50% of their activity when it is 
exposed to sunlight or any UV light. On the other hand, when riboflavin is heated, for example 
when some food product that contains riboflavin is cooked, the riboflavin keeps their stability.  
However, in milk pasteurization riboflavin loses about 20 % of it activity and in food sterilization 
with radiation or ethylene oxide completely destroid. For food industry is important to solve this 
instability and to protect riboflavin properties in food products. Actually, the riboflavin is availed in 
oral preparation (alone or most commonly in multivitamin preparations) or as an injectable 
solution and due to their properties and yellow color, it also used to enrichment and provide color 
and/or flour of food and beverages (Spitzer and Schweigert, 2007). 
 
2.4.1.2 Tocopherol (Vitamin E) 
The term vitamin E includes eight fat soluble components that are found in nature: four called 
tocopherols (α-, ȕ-, Ȗ- and δ-tocopherol) and four tocotrienols (α-, ȕ-, Ȗ- and δ-tocotrienols); being 
the most common and biologically active α-tocopherol. The vitamin E was first isolated from 
wheat germ in 1936 and the name tocopherol is derivate from Greek word tocos that are mean 
“to bring forth in childbirth” due to its essential role in the reproduction of various species. In 
1937 the structure and synthesis was clarified and the ending –ol was added to the name for 
identifies the substance as an alcohol (Ball, 2008; Gonnet et al., 2010; Spitzer and Schweigert, 
2007).  
The vitamin E is a liposoluble vitamin as vitamin A, D and K, being necessary the presence of 
lipids, bile and pancreatic juice for their absorption in the human organism. This vitamin is an 
organic molecule composed by a chromanol ring and a phytol side chain that can be eight 
different conformations: tocopherols have a saturated side chain and tocotrienols have three 
conjugated double bonds, where α-, ȕ-, Ȗ- and δ- prefixes indicated methyl groups position on 
chromanol ring, (Figure 2.12).  Although, the tocopherols and tocotrienols have different 
structures, they present similar functions (Gonnet et al., 2010). 
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Figure 2.12 – Chemical structure of α-tocopherol.  
Image from http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=14985 (September 19, 
2013). 
 
Actually, is known different positive effects of vitamin E, for example, on cardiovascular, immune, 
reproduction systems, and also in cancer prevention and protection of membrane lipids against 
oxidation. The most important of sources of vitamin E are vegetable oils, nuts, whole grains and 
wheat germ, having vegetables, fruits, fish and meat a relatively low content. The absence of this 
vitamin has been linked to neurological disorders, but is reversible whit ingestion of vitamin E 
supplements or through food and beverages fortified with vitamin E (Gonnet et al., 2010; Wagner 
and Chen, 2004). However, the food industry has a great challenge to solve: improve physical 
stability of vitamin E in beverages and food. Due to the insolubility of vitamin E in water it is 
necessary create a system that can be used in fortification of food products and improve the 
solubility/stability of vitamin. Another problem is the turbidity of beverages in the presence of 
vitamin E. For an ideal food product, it’s important a good physical stability and normal 
appearance. This way, again, micro- nanoencapsulation appears as a good solution, being used, 
for example, biopolymers with starch or liposomes or clusters of molecules such as cyclodextrin  
(Spitzer and Schweigert, 2007; Wagner and Chen, 2004).  
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3.1. DEVELOPMENT OF NANOPARTICLES  
3.1.1 ALGINATE/CHITOSAN NANOPARTICLES PREPARATION 
3.1.1.1 Materials 
Sodium alginate with MW 15900 Da and viscosity  200 cp from Laminaria hyperborea was 
purchased from Manutex RSX (Kelco International, Ltd., Portugal). Chitosan with 91.23% 
deacytelation degree was purchased from Golden-Shell Biochemical Co., Ltd (China). Calcium 
chloride (CaCl2) was obtained from Panreac (Panreac Quimica SA, Barcelona, Spain) and the 
component bioactive, (-)-riboflavin, with 376.36 g/mol of molecular mass was obtained from 
Sigma-Aldrich Chemical Co. Ltd (St. Louis, MO, USA). 
 
3.1.1.2 Methodology 
The development of alginate/chitosan nanoparticles was based the methodology described by 
Sarmento et al. (2007).  Ionotropic pre-gelation method followed by polycationic crosslinkg was 
used as production method and the biopolymers alginate and chitosan were used as main 
materials. Briefly, alginate was dissolved in distilled water and the chitosan was dissolved in 1 % 
acetic acid and the pH of alginate and chitosan solutions was initially set to 4.9 and 4.6, 
respectively. Through a preliminary study (ANNEX A), the optimal concentrations (selected based 
in the particle size and PDI) of alginate and chitosan were determined, being, respectively, 0.63 
mg/mL and 0.4 mg/mL. then, 7.5 mL of 18 mM calcium chloride solution was dropped at a 
flow rate of 0.125 mL/min into a beaker containing 117.5 mL of alginate solution at a constant 
homogenization using an Ultra-Turrax (T 25, Ika-Werke, Germany) at 20 000 rpm. Then, 25 mL 
of chitosan solution were added dropwise into the previous solution with a stirring of 600 rpm 
and a flow rate of 0.278 mL/min. After the addition of chitosan solution, alginate/chitosan 
nanoparticles were maintained at constant stirring during 30 minutes. For the water-soluble 
vitamin encapsulation, (-)-riboflavin was dissolved in the alginate solution before addition of 
calcium chloride solution. Different concentrations of vitamin were tested (0.0475, 0.065, 0.095, 
0.13 and 0.19 mg/mL) based on the maximum solubility and the optimal concentration of 
vitamin was determined (selected based in particle size and PDI), being 0.065 mg/mL. For 
nanoparticles preparation were used a syringe pump (NE-1000 MultiphaserTM Programmable 
Syringe Pump, New Era Pump Systems Inc.), two polypropylene syringes, one of 10 mL (Injekt 
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10 mL Luer) and other of 50 mL (Ominifix® 50 mL Luer), obtained from B|Braun Ltd. 
(Melsungen, Germany) and still needles of 0.60 x 25 mm (100 Sterican®, B|Braun Ltd.). 
 
3.1.2 ZEIN NANOPARTICLES PREPARATION 
3.1.2.1 Materials 
Corn zein with 88.0 to 96.0% of protein content was obtained from Acros Organics (Geel, 
Belgium). ( )-α-Tocopherol (TOC) with 98% purity and molecular mass of 430.7 g/mol was 
purchased from Sigma-Aldrich Chemical Co. Ltd (St. Louis, MO, USA) and ethanol absolute PA 
(M=46.07) obtained from Panreac (Panreac Quimica SA, Barcelona, Spain). 
 
3.1.2.2 Methodology 
Nanoparticles were prepared using a self-assembly method where a zein solution (dissolved in 
75% aqueous ethanol solution) was used as a main material.  
Initially, were tested different parameters for zein nanoparticles preparation ANNEX A, and were 
determined the optimal parameters. Briefly, 10 mL of zein solution (2 mg/mL) at flow rate of 
0.167 mL/min were dropwise in 50 mL of distilled water with a constant stirring of 700 rpm. 
After zein solution addition, zein nanoparticles were maintained in constant stirring for 15 
minutes. For this process were used a syringe pump (NE-1000 MultiphaserTM Programmable 
Syringe Pump, New Era Pump Systems Inc.), a polypropylene syringe of 10 mL (Injekt 10 mL 
Luer, B|Braun Ltd) and a needle of 0.60 x 25 mm (100 Sterican®, B|Braun Ltd.).  
For the encapsulation of compound bioactive, TOC was dissolved in zein solution and then was 
dropwise in distilled water following the procedure described before. The optimal concentration of 
TOC was 1 mg/mL (selected based in the maximum solubility and preliminary studies).  
 
3.2 CHARACTERIZATION 
3.2.1 NANOPARTICLE SIZE, POLYDISPERSITY INDEX AND ZETA POTENTIAL 
Size, polydispersity index (PDI) and zeta potential of nanoparticles were measured through 
dynamic light scattering (DLS) (Zetasizer Nano ZS, Malvern Instruments, UK) equipped with a He-
Ne laser at a wavelength of 633 nm. For size and PDI determination polystyrene cuvettes were 
used (12 mm Square Polystyrene Cuvettes (DTS0012), Malvern Instruments, UK) and for zeta 
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potential disposable capillary cell (Disposable capillary cell (DTS1070), Malvern Instruments, 
UK). 
All measurements were performed at 25 °C. Each measurement of size and PDI were measured 
with a detection angle of 173° and zeta potential measurements an angle of 17°, being the 
potential zeta values calculated by Smoluchows i’s model. For all size, PDI and potential zeta 
measurements were performed at least three replicates.  
Before the measurements, the samples of alginate/chitosan nanoparticles with vitamin 
encapsulated were centrifuged (MIKRO 120, Andreas Hettich GmbH & Co. KG). Through a 
preliminary study, the optimal velocity and time was determined (selected based in the particle 
size and PDI), being at 4601.7 g during 5 minutes.  
NanoSight NS500 (NanoSight Ltd., UK) was also used to measure the size of nanoparticles and 
to analyze the nanoparticles concentration by size. For measurements the samples were diluted 
to a concentration suitable for the analysis (according to the equipment instructions) (NanoSight, 
2010). The dilutions were made with distilled water for alginate/chitosan nanoparticles and with 
a 75% ethanol solution for zein nanoparticles. The diluted samples were injected into the sample 
chamber fitted with a 640 nm diode laser. For capturing and analyzing the data was used the 
software Nanoparticle Tracking Analysis (NTA) 2.0 Build 127.  
 
3.2.2 ENCAPSULATION EFFICIENCY AND LOADING CAPACITY 
Encapsulation efficiency (EE) and loading capacity (LC) were determined after the separation of 
nanoparticles with encapsulated vitamin and the solution with free vitamin. The separation was 
obtained using membrane separation method with an Amicon® Ultra-0.5 centrifugal filter device 
(Amicon® Ultra - 0.5 mL 3K device, Millipore Corp., Ireland). So, 0.5 mL of sample (solution 
containing nanoparticles with encapsulated and free vitamin) was added to the Amicon® and was 
centrifuged at 14 000 g during 10 minutes. From centrifugation was obtained a filtrate with free 
vitamin and a concentrate with nanoparticles with encapsulated vitamin that were used for EE 
and LC determination (please see Figure 3.1). To calculate EE, the filtrate was assayed 
spectrophotometrically and the amount of free vitamin was calculated by appropriate calibration 
curve (ANNEX C). In its turn, to calculate LC the concentrate was dried and the weight of 
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nanoparticles determined. EE and LC was calculated as follows (Luo et al., 2011, 2012; 
Sarmento et al., 2007): 
EE      it total    it free it total        Eq. 3. 2 
LC      it total    it freeNps total        Eq. 3.3 
Where Vit total represents total amount of vitamin; Vit free the amount of free vitamin in filtrate 
and Nps total the total weight of nanoparticles. 
For the nanoparticles with (-)-riboflavin, the absorbance of filtrate was measured in a multi-
detection microplate reader BioTeK SynergyTM HT (BioTek Instruments, Inc., USA) at 437 nm, 
which corresponds to maximum absorbance peak of (-)-riboflavin (Bajpai and Tankhiwale, 2006). 
For this measurement was used a plate of 96 wells. The amount of free (-)-riboflavin was 
calculated through the calibration curve of (-)-riboflavin in distilled water: y   33.77x – 0.0049 (R2 
  0.999) (please see ANNEX C). 
For TOC, before to calculate free TOC in filtrate was determined the maximum absorbance peak 
being made a scan over the range 200 – 400 nm using UV – Vis spectrophotometer Jasco V-560 
(Tokyo, Japan) (ANNEX B). Then, the absorbance of filtrate was assayed spectrophotometrically 
at 292 nm (maximum absorbance peak determined) and the amount of free TOC in filtrate was 
calculated through calibration curve y   7.5582x + 0.0004 (R²   0.997) (please see ANNEX C). 
 
 
 
    
 
 
 
 Figure 3.1 – Membrane separation method with an Amicon® ultra-0.5 centrifugal filter device. Image 
adapted from User Guide Amicon® ultra-0.5 centrifugal filter device. 
Free 
vitamin 
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3.2.3 MORPHOLOGY 
The surface morphology of the nanoparticles with and without vitamin was evaluated through a 
transmission electron microscope (TEM) ZEISS 902 A (Zeiss, Germany) operating at a voltage of 
80 kV. Before loading of samples into the microscope (direct deposition), the samples were drop-
cast onto a carbon coated copper grid and grid was dried during 1 minute at room temperature. 
 
3.2.4 RELEASE PROFILE 
In order to evaluate the release profile of encapsulated vitamins from nanoparticles the dialysis 
membrane method was used (Beirão da Costa et al. 2012; Pinheiro et al. 2012).The release 
experiments were conducted at 37 and 25 °C and the medians utilized were phosphate buffer 
saline (PBS) pH 7 and Tris-Hydrochloride (Tris-HCL) pH 2. 
 
3.2.4.1 Materials 
PBS in tablets was purchased Sigma-Aldrich Chemical Co. Ltd (St. Louis, MO, USA) and was 
dissolved in distilled water. Tris-HCl was prepared with 0.2 M potassium chloride from Merk 
(Darmstadt, Germany) and 0.2 M Hydrochloric acid (36.5-38 % of purity) that was obtained from 
Sigma-Aldrich Chemical Co. Ltd (St. Louis, MO, USA).  
 
3.2.4.2 Dialysis membrane method  
The release profile of (-)-riboflavin from alginate/chitosan nanoparticles and of TOC from zein 
nanoparticles were evaluated by dialysis membrane method. Before procedure, nanoparticles 
with encapsulated vitamin were separated from the aqueous medium containing free vitamin 
using an Amicon® Ultra-0.5 centrifugal filter device and for dialysis method was used the 
concentrate (nanoparticles with vitamin entrapped) (Figure 3.1).  
The procedure of dialysis membrane method was as follows: 5 mL of nanoparticles with 
encapsulated vitamin were added into a dialysis membrane (molecular weight cut-off 3500 Da; 
Cell-Sep H1, Membrane Filtration products, USA) and the sealed membrane was then placed into 
50 mL of buffer solution (PBS or Tris-HCl) at 37 or 25 °C, with magnetic stirring. At determined 
time intervals, 1 mL samples were taken from the medium and replaced by fresh medium to 
maintain the original volume. All the experiments were performed in triplicate. 
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Vitamin concentration was determined at 437 nm in multi-detection microplate reader BioTeK 
SynergyTM HT for (-)-riboflavin and at 292 nm for TOC using a UV – Vis spectrophotometer Jasco 
V-560. The (-)-riboflavin and TOC concentration were calculated by calibration curves (ANNEX C): 
y   33.77x – 0.0049 (R2   0.999), and y   7.5582x + 0.0004 (R²   0.997), respectively.  
 
3.2.4.3 Kinetics of Release 
The release profile of encapsulated vitamin in nanoparticles was evaluated through the 
relationship between the size of the particles and the release fraction of vitamin at time t that can 
be described by equations 3.3 and 3.4:  
Mt
M     ( Dtπ r ) .   3Dtr   for  MtM     .  Eq. 3.3  
Mt
M      .   exp ቆ Dtπ r ቇ   for  MtM     .  Eq. 3.4  
Being Mt the solute mass released at time t; M the solute mass released at infinite time when 
equilibrium is achieved; r is the radius of the nanoparticles and D can be calculated from Eq. 3.3 
and 3.4 by non-linear parameter estimation (Beirão da Costa et al., 2012; Prata et al., 2008). 
In order to determine the suitable of equations in describing the vitamin release data over the 
time, it was used the non-linear estimation module of Statistica®7(Statsoft, Tulsa, Ok, USA). 
 
3.2.5 STABILITY MEASUREMENT 
The freshly prepared samples were used for stability measurements. In order to evaluate the 
stability of nanoparticles, the samples were subjected to different parameters such as 
temperature and storage time and nanoparticle size and PDI measured. All measurements were 
performed in triplicate. 
 
3.2.5.1 Temperature  
The effect of temperature in nanoparticles was evaluated using Standard Operating Procedure 
(SOP) Temperature Size Trend of DLS instruments (Zetasizer Nano ZS). For these measurements 
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was used 1 mL of sample that was placed in a glass cell with circular aperture and stopper (12 
mm Square Glass Cell for 90 sizing (PC S8501)), Malvern Instruments, UK) and was made a 
measurement of the nanoparticles size and PDI over the range 25 – 90 °C, with a temperature 
interval of 2.5 °C. 
 
3.2.5.2 Storage Time  
In order to evaluated the stability of nanoparticles throughout time, nanoparticles samples with 
and without vitamin were stored in a fridge at 4 °C being size and PDI of nanoparticles measured 
during five months.  
Before the measurements samples of alginate/chitosan nanoparticles with vitamin encapsulated 
were centrifuged (MIKRO 120) at 4601.7 g during 5 minutes.  
 
3.3 STATISTICAL ANALYSES 
Data analyses were performed using Microsoft Windows Excel 2003 and GraphPad Prism 
(Version 5.00 (Trial), edition 2007, GraphPad Software, Inc., La Jolla, CA, USA). All data were 
reported as the mean   standard deviation (SD) from at least three values. The analysis of 
variance (ANO A) followed by Tu ey’s multiple-comparison (α=0.05) were employed to assess 
the statistical significance of results between groups. Experimental results were considered 
statistical significant at 95 % confidence level (p<0.05). 
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The main objective of this work was the development of nanosystems for encapsulation of 
vitamins using biopolymers and their further characterization. Therefore, two nanosystems were 
developed and characterized, one for water-soluble vitamins and other for liposoluble vitamins. 
Encapsulation of water-soluble vitamins was performed through ionotropic polyelectrolyte pre-
gelation method using two charged polysaccharides, alginate and chitosan. For liposoluble 
vitamins a protein-based nanosystem was developed, through the self-assembly of zein. This 
chapter is divided in “ALGINATE CHITOSAN NANOPARTICLES” and “ZEIN NANOPARTICLES”; 
where are presented the main results obtained during the development and characterization of 
the nanosystems and its discussion.  
 
4.1 ALGINATE/CHITOSAN NANOPARTCILES  
Alginate/chitosan nanoparticles were produced using the ionotropic pre-gelation method followed 
by polycationic crosslink, being used CaCl2, alginate and chitosan as main materials, and (-)-
riboflavin (vitamin B2) as water-soluble vitamin model. During nanoparticles formation Ca2+ ions 
are into alginate solution, the Na+ ions of alginate “are removed” and electrostatic interactions 
between –COO- groups of alginate and cross-linked Ca2+ ions are promoted. Then, with chitosan 
addition, the alginate molecules also crosslinks with chitosan through electrostatic interactions 
between negatively charged –COO- group of alginate and positively charged protonated amine 
groups of chitosan (Figure 4.1) and this way are formed alginate/chitosan nanoparticles (Bajpai 
and Tankhiwale, 2006).  
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Based on the methodology described by Sarmento et al. (2007), due the great complexity of the 
method and being used an alginate and chitosan with different properties, it was needed to test 
different formulations and parameters during its production. So, initially an optimization was done 
being the nanoparticles formulation and parameters used for their production determined. 
  
4.1.1 OPTIMIZATION OF THE FORMULATION 
The particle size and polydispersity index (PDI) are essential parameters to evaluate the stability 
and homogeneity of nanoparticles in solution, being considered, in this case, the most important 
factors during the optimization of the nanoparticles. So, the effects of different formulations and 
parameters in particle size and PDI were analyzed in order to optimize the formulation, being 
measured through DLS instrument (Zetasizer Nano ZS). The preparation conditions of 
alginate/chitosan nanoparticles have been optimized in terms of the polysaccharides and vitamin 
concentrations, flow rates of solutions, time and velocity of shake and centrifugation. In ANNEX A 
are summarized the effects of different formulations on particle size and PDI. 
The optimized formulation was 0.63 mg/mL and 0.4 mg/mL of alginate and chitosan, 
respectively, with 0.065 mg/mL of (-)-riboflavin loaded. 
 
 
Ca2+ 
Na+ 
COO-Na+ 
(– O – O – O –)n 
COO-Na+ COO-Na+ 
COO- 
(– O – O – O –)n 
COO- COO- 
COO- 
(– O – O – O –)n 
COO- COO- 
Ca2+ Ca2+ 
(– O – O – O –)n 
+NH3 +NH3 
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+ 
COO- 
(– O – O – O –)n 
COO- COO- 
COO- 
(– O – O – O –)n 
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(– O – O – O –)n 
+NH3 +NH3 
+NH3 
Ca2+ 
Figure 4.1 – Electrostactic interactions between Ca2+ ions, -COO- groups of alginate and amine groups of 
chitosan. Image adapted from Bajpai and Tankhiwale (2006). 
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4.1.2 CHARACTERIZATION 
After previous study, the alginate/chitosan nanoparticle with and without (-)-riboflavin was 
characterized in terms of particle size (by z-average and number), PDI, zeta potential, 
morphological observation, encapsulation efficiency (EE), loading capacity (LC), release profile 
and stability measurements. Below, are presented the characterization of alginate/chitosan 
nanoparticles. 
 
4.1.2.1 Size, Polidispersity index (PDI) and Zeta Potential  
Table 4.1 shows the average of particle size, PDI and zeta potential values for alginate/chitosan 
nanoparticles prepared with and without (-)-riboflavin.  
The alginate/chitosan nanoparticles with and without (-)-riboflavin present different sizes 
represented by z-average and number distribution, being in the both cases the z-average higher 
than the particles size by number. The z-average values are obtained by intensity of the particles 
in solution and the large particles scatter much more light than small particles, on the other 
hand, the number distribution take account the number of the particles in solution (Malvern 
Instruments, 2004). This way, the z-average of 512.2 (  36.80) nm and 428.2 (  31.09) nm for 
nanoparticles with and without vitamin, respectively, is due to the particles or aggregates 
presents in samples with a size above 500 nm that scatter more light than smaller particles. Like 
this, the results showed that nanoparticles of alginate/chitosan with and without (-)-riboflavin 
have particles or aggregates with a size above 500 nm. However, the distribution by number 
shows that samples have a great number of nanoparticles with a mean size of 
119.5 (  49.86) nm for samples without (-)-riboflavin and 104.0 (  67.24) nm with (-)-riboflavin.  
PDI values for nanoparticles without and with vitamin are 0.454 (  0.066) and 0.319 (  0.068), 
respectively. In general, the PDI above 0.2 indicate that the sample do not exhibit a good 
homogeneity (Silva et al., 2011b). For this reason, the samples are not considered 
monodisperses. Besides that, the standard deviations of particle size are high; also indicating 
those samples was not homogenous. Considering the difference between z-average and number 
distribution, the PDI values and the standard deviations obtained are consistent with this result. 
The means of particles size by z-average and PDI for alginate/chitosan nanoparticles without and 
with (-)-riboflavin are significantly different (p<0.05), decreasing when the vitamin is loaded in 
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alginate/chitosan nanoparticles. However, the decrease of size by number distribution is not 
significantly different (p>0.05) showing that encapsulation of vitamin does not influence the 
values of size distribution by number. The decrease of size distribution can be explained by 
interactions between (-)-riboflavin and both biopolymers used. (-)-Riboflavin can have a cationic 
form (RFH2+) at low pH, neutral form (RFH) and anionic form (RF-) at high pH (Choe et al., 
2005), and when mixed with alginate solution at pH 4.7, the (-)-riboflavin acquire cationic form 
interacting strongly with negatively charged alginate. So, the smaller sizes in samples with (-)-
riboflavin can be explained by the strong ionic interaction between riboflavin and alginate but may 
also take into account hydrogen bonding and van der walls forces that (-)-riboflavin can establish 
with alginate and chitosan (Sarmento et al., 2007).   
The zeta potential is indicative if samples have a good colloidal stability, being particles with zeta 
potentials more positive than +30mV or more negative than -30mV normally considered stable 
(Malvern Instruments, 2004; Silva et al., 2011b). The values obtained were -30.89   0.51 and -
29.64 ± 0.97 mV without and with vitamin, respectively, showing that samples have a good 
colloidal stability. These values are also statistically significantly different (p<0.5), showing that 
vitamin-loaded can influence zeta potential (Table 4.1). The zeta potential for nanoparticles with (-
)-riboflavin higher than the values for nanoparticles without (-)-riboflavin can also be explained by 
the cationic form that (-)-riboflavin acquire in solutions with pH below that favors the negative 
charge of the solution. 
Table 4.1 – Particle size (by z-average and number), Polydispersity index (PDI) and Zeta Potential for 
alginate/chitosan nanoparticles with and without (-)-riboflavin, by DLS instrument (Zetasizer Nano ZS). 
(-)-Riboflavin 
content 
Particle size  
PDI 
Zeta Potential 
(mV) z-average (nm) number (nm) 
Without 512.2   36.80 a 119.5   49.86 a 0.454   0.066 a -30.89   0.51 a 
With 428.2   31.09 b 104.0   67.24 a 0.319   0.068 b -29.64   0.97 b 
Values are expressed as mean   standard deviation. 
a,b – Different letters in same column indicate a statistically significant difference (p<0.05) 
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Due to differences between z-average and number distribution and in order to confirm the sizes 
of nanoparticles obtained by DLS, also NTA was used to measure the size of particles. The 
results obtained by NTA are presented in Table 4.2, being presented the mean and mode of 
particle size. 
 
Table 4.2 – Particle size (mean and mode) for alginate/chitosan nanoparticles with and without (-)-
riboflavin, by NTA (NanoSight). 
(-)-Riboflavin 
content 
Particle size (nm) 
Mean  Mode 
Without 168   97 101 
With 210   109 107 
Values obtained by software Nanoparticle Tracking Analysis (NTA) 
2.0 Build 127 expressed as mean   standard deviation. 
Nanoparticles sizes obtained by NTA are consistent with results obtained by number distribution 
in DLS. Although, the standard deviation associated to the mean of particle size is high, but as 
the mode is a value more common in sample the size number distribution obtained by DLS was 
considered real size of the nanoparticles.  
Particle size influences many properties of particulate materials and is a valuable indicator of 
quality and performance. A small particle size is important because are more efficiently 
absorption by the gastrointestinal track increasing their biodisponibility (Sarmento et al., 2006, 
2007).  
 
4.1.2.2 Morphological observation 
The morphological observation of alginate/chitosan nanoparticles were performed by TEM. 
Figure 4.2 the representative photographs of the alginate/chitosan nanoparticles without (-)-
riboflavin. 
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Figure 4.2 – Transmission electron microscopy (TEM) images of alginate/chitosan nanoparticles without  
(-)-riboflavin at a scale bar of  2 µm, 7000x (a); 1 µm, 12000x (b); 0.5 µm, 20000x (c). 
 
TEM images show that alginate/chitosan nanoparticles have an evident spherical shape and no 
aggregations of nanoparticles are observed; however the size distribution of the particles was not 
homogeneous varying from 100 to 1000 nm. Figure 4.2a shows a broader picture of the sample 
and it is possible to see a great amount of nanoparticles with a smaller size (<200 nm) but also 
some particles with size above 500 nm. This image, not only confirms the high values of 
polydispersity index (>0.2) and standard deviation associated to the means of particles sizes, but 
also the difference between z-average and mean size by number. 
This TEM pictures revealed a differences of contrast between the external polymeric membrane 
and internal part of nanoparticles and this difference is due to the difference between measured 
electrical conductivity of alginate (1.40   0.2 mS/cm) and that of chitosan (1.47   0.01 
mS/cm), which renders alginate to be the first to become electrically charged after the incidence 
of the electron beam during TEM analysis (Carneiro-da-Cunha et al., 2010). So, as expected, the 
chitosan is the external polymeric membrane and the alginate is the internal part of the 
nanoparticles. 
 
4.1.2.3 Encapsulation Efficiency and Loading Capacity 
The capacity of the nanoparticles to encapsulate water-soluble vitamins was evaluated through 
the determination of the encapsulation efficiency (EE) and loading capacity (LC). The values of EE 
and LC obtained were 55.91(  5.56) % and 2.18 (  0.63) %, respectively. These values are lower 
than those reportered for other systems for (-)-riboflavin. Abd El-Ghaffar et al. (2012) obtained 
values of EE in the range of 80 - 100 %, however the particles sizes were more higher than the 
(a) (b) (c) 
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values obtained in present work, presenting sizes of 1.4 (  0.05) mm (El-Ghaffar et al., 2012). 
For others alginate/chitosan nanoparticles, e.g. with insulin-loaded, Sarmento et al. (2007) 
obtained EE values between 70 and 90% and LC in the range 5 – 15 %, but the mean of particles 
sizes were between 700 and 4000 nm (Sarmento et al., 2007) and Goycoolea et al. (2009) 
obtained EE values similar those obtained in this work ( 50 ) and the sizes of particles are 
between 200 and 300 nm (Goycoolea et al., 2009).  
So, and besides the higher values of EE and LC obtained in others works, the results obtained 
show that alginate/chitosan particles at the nanoscale present good values of EE and LC. 
 
4.1.2.4 Release profile of (-)-riboflavin from alginate/chitosan nanoparticles 
The release profile allows knowing the prediction of the in vivo behavior of an encapsulated 
bioactive compound, allowing to know if the developed nanoparticles are appropriated to the 
proposed application (e.g. application in food industry). Release experiments were conducted at 
37 and 25°C being the buffers used PBS (pH 7) and Tris-HCL (pH 2). While the temperature at 
37°C tries to simulate the temperature of the human digestive system, pH 2 pretends to simulate 
the stomach and pH 7 the intestine. The temperature at 25°C intends to simulate the food 
and/or beverages at ambient temperature. So, the release profile can be defined as a method by 
which a bioactive compound is made available at a desired site and time and at a specific rate 
(Beirão da Costa et al., 2012), being, in present work, evaluated the effect of temperature and 
pH on vitamin release rate from alginate/chitosan. 
Figure 4.3 shows the fitting of Eq. 3.3 to the experimental data of (-)-riboflavin release kinetics 
from alginate/chitosan nanoparticles, for pH 7 and 2 at 37 and 25°C, and it is possible to see a 
good agreement between experimental and model-generated values suggesting that this 
mathematical model describes well the physical mechanism associated to the (-)-riboflavin 
release. Also, it is possible to see that (-)-riboflavin release profiles showed a biphasic modulation: 
initially, the release profile is relatively fast (“burst effect”) and then is followed by a continuous 
and controlled slow release phase (“lag time”) (Beirão da Costa et al., 2012). One explanation for 
the “lag time” observed following of “burst effect”, can be the vitamin distribution across the 
nanoparticle and this way connot diffuse easily out the membrane and the vitamin release slower 
(She et al., 2010). The burst effect at 37°C is for at least 50 and 5 minutes for pH 7 and 2, 
respectively, and at 25°C is during the first 60 minutes to pH 7 and 40 minutes for pH 2. 
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Figure 4.3 – Fitting of Eq. 3.3 to (-)-riboflavin controlled release experimental data from alginate/chitosan 
nanoparticles ((•) experimental results  and ( o ) model-generated values): (a) at 37°C, pH 7; (b) at 37°C 
pH 2; (c) at 25°C, pH 7; (d) at 25°C, pH 2. 
The initial “burst effect” can be explained based on the effect of pH in biopolymers used: alginate 
and chitosan.  The decrease of the pH, can lead to disintegration, relaxation and swelling of the 
nanoparticles and, consequently, the release of the encapsulated vitamin.  
Into the PBS buffer at pH 7 the NH3+ groups of chitosan get deprotonated to yield uncharged 
NH2 groups and, this way, is reduced their electrostatic interactions with –COO- groups of 
alginate chains. Consequently, the nanoparticles begin to disintegrate along the release of the 
encapsulated vitamin. The disintegration of alginate/chitosan nanoparticles can also be due to 
ion exchange between Na+ ions from the PBS and Ca2+ ions from the egg-box cavities of 
polyguluronate blocks of alginate (Bajpai and Tankhiwale, 2006). Moreover, the swelling is 
(a) (b) 
(d) (c) 
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increased in PBS medium, because the carboxylate groups of alginate molecules tend to ionize 
and give –COO- ions which facilitate the swelling of nanoparticles. The osmotic pressure should 
increase inside the nanoparticles due to the higher concentration of free H+ and promote water 
uptake. Furthermore, electrostatic repulsion between carboxylate ions should cause 
macromolecular chain relaxation and increase swelling, and, thus contribute to release of vitamin 
(El-Ghaffar et al., 2012; Sarmento et al., 2007).  
When alginate/chitosan nanoparticles are placed in Tris-HCl buffer at pH 2, the negatively 
charged carboxylate groups of alginate begin to protonate to form uncharged –COOH groups. 
This reduces the degree of crosslinking due to the decrease of ionic and electrostatic interactions 
among the alginate and chitosan chains within the nanoparticles, thus resulting in loosening of 
nanoparticle structure with subsequent faster release of encapsulated drug (Bajpai and 
Tankhiwale, 2006).  
Based on this fitting was calculated the diffusion coefficient (D) for release of (-)-riboflavin 
encapsulated into alginate/chitosan nanoparticles, being at 37°C of 2.28     -   and 
4.95   0.74     -   m  s to pH 7 and 2, respectively, and at 25 °C of 1.02     -   m  s for pH 
7 and 1.88     -   m  s for pH 2. At both temperatures, the D values in pH 2 are higher than in 
pH 7, which can explain the different time of “burst effect”. However, comparing the D values, at 
37 °C are higher than at 25 °C pointing out that the temperature can have influence on the 
diffusion of molecules through alginate/chitosan nanoparticles. The gel point (the critical point 
where gel first appears) of alginate and chitosan is about 32 °C and can explain the difference 
between D values at 37 °C and 25 °C because at 37 °C may have induced the gel form of 
alginate and chitosan leading to increase of polymers branch and, consequently, increase of 
nanoparticles sizes and release of bioactive compound (Liang et al., 2004).  
 
4.1.2.5 Stability measurement  
One of major applications of the vitamin-loaded alginate/chitosan nanoparticles is food industry. 
So, is important to guarantee that nanoparticles maintain their chemical and physical stability 
during processing and storage (Silva et al. 2011). The nanoparticles stability was assessed by the 
evaluation of the effect of some parameters such as temperature and storage time in 
alginate/chitosan nanoparticles without vitamin. 
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Temperature 
The Figure 4.4 shows the effect of temperature in particle size and PDI of alginate/chitosan 
nanoparticles without (-)-riboflavin: until 35 °C the nanoparitcles sizes are not influenced by 
temperature (p>0.05), however, from 35 °C to 37.5 °C happens a significant increase of 
nanoparticles sizes (p<0.05). Between 37.5 °C and 90 °C the nanoparticles sizes are stable 
again with values ranged from 372.84 (  138.94) to 314.65 (  26.20) nm. Considering the 
values of PDI (>0.2) and the standard deviation associated of the means, the samples until 35°C 
are not homogenous being more homogenous with temperature increase. This way, this study 
shows that temperature increase is responsible not only for increase of alginate/chitosan 
nanoparticles sizes but also by samples more homogeneous.   
As mentioned previously, the alginate and chitosan have gelling properties and some external 
parameters, such as pH, temperature, ionic strength, solvent composition and electrical fields, 
can induce these gelling properties (Carreira et al., 2010). The gelation refers to the linking of 
molecules that lead to progressively larger branched polymers, initially, depending on the 
structure and conformation of the starting polymer, yet soluble. However, the continuation of the 
linking process results in increasing the size of the branched polymer and the solubility decrease 
(Gulrez et al., 2011). In present assay, the increase of temperature may have induced the gel 
form of alginate and chitosan, because, as previously mentioned, the gel point of alginate and 
chitosan is about 32°C (Liang et al., 2004). This way, the increase of nanoparticles sizes can be 
explained by increase of polymers branch.   
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Figure 4.4 – Effect of temperature in particle size and PDI of alginate/chitosan without (-)-riboflavin. 
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Storage time 
The stability of nanoparticles over time is important to determination of time that nanoparticles 
keep stable. The stability of samples was studied during five months, being used DLS for 
measurement of size and PDI of alginate/chitosan nanoparticles. Figure 4.5 shows that sizes of (-
)-riboflavin-loaded nanoparticles are more stable than nanoparticles without (-)-riboflavin, being 
the PDI of alginate/chitosan nanoparticles with (-)-riboflavin smaller than (p<0.05) without 
vitamin. This fact can be explained by interactions between riboflavin and biopolymers used: (-)-
riboflavin besides the ionic interactions that can establishes with alginate hydrogen bonding and 
van der Walls forces with alginate and chitosan (Sarmento et al., 2007).  
Following initial nanoparticle characterization, the chemical stability of the samples was evaluated 
by determination of the pH after preparation of the alginate/chitosan nanoparticles without and 
with (-)-riboflavin, being obtained pH values of 4.6 for both systems. Over the course of five 
months, the pH increase to 5.4; this significant increase can be due to alteration of the charges 
present in the alginate and chitosan polymer chains. This way, the nanoparticles are instable and 
the nanoparticles sizes increase (El-Ghaffar et al., 2012; Sarmento et al., 2006). In Figure 4.5 is 
possible to see that the alginate/chitosan nanoparticles without (-)-riboflavin was more affected 
with alteration of pH than the alginate/chitosan nanoparticles with (-)-riboflavin, because the sizes 
increase over the course of five months and PDI are higher.  
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Figure 4.5 – Stability of alginate/chitosan nanoparticles: (a) without (-)-riboflavin; (b) with (-)-riboflavin. 
 
 
 
  
(b) 
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4.2 ZEIN NANOPARTICLES 
The development of nanoparticles for encapsulation of liposoluble vitamin, ( )-α-tocopherol 
(vitamin E), was performed using zein as main material and self-assembly as production method. 
As previously described, zein is insoluble in water and the main driving forces for self-assembly is 
amphiphilicity. But for nanoparticles formation it is also important to exist a long-range repulsion, 
for example, thermodynamic incompatibility, phase separation, excluded volume and columbic 
repulsion, between the protein and the medium. This way, in present work, the zein dissolved in 
75 % aqueous ethanol solution was dropped in water and without help or guidance from external 
agents were formed nanoparticles of zein. When TOC is added, are established hydrophobic 
interactions and electrostatic interactions between TOC and zein that contribute to the 
encapsulation of TOC into zein (Luo et al., 2011) (Figure 4.6). Initially, was done an optimization 
and was determined the formulation and the optimal parameters for the production of 
nanoparticles (based in size of particles and PDI). This optimization is increasingly important for 
compound delivery and controlled release, because small particle sizes are believed to affect 
particle absorption at the intestinal lumen and their longevity in the blood stream (Wang and 
Padua, 2012b). After to determine the optimal formulation and parameters for nanoparticles 
preparation the vitamin was added to the system and zein nanoparticles characterized. 
 
 
 
 
 
 
 
 
 
 
 
Dropped in 
water  
Zein (ethanol solution) 
TOC 
Figure 4.6 – Schematic illustration of formation of zein nanoparticles with TOC. Image adapted from Luo 
et al. 2011. 
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4.2.1 OPTIMIZATION OF THE FORMULATION 
As mentioned previously, the particle size and PDI are essential parameters to evaluate the 
stability and homogeneity of nanoparticles in solution. So, is important to study the effect of 
process parameters in particle size and PDI. The preparation conditions of zein nanoparticles 
have been optimized in terms of the protein and vitamin ratio, flow rates of solutions, time and 
velocity of shake and centrifugation. In ANNEX A are summarized the effects of different 
formulations on particle size and PDI. 
 
4.2.2 CHARACTERIZATION 
The nanoparticles of zein with and without TOC was characterized using the same parameters 
used for alginate/chitosan nanoparticles characterization (particle size by z-average and number 
distribution, PDI, potential zeta, morphological observation, encapsulation efficiency (EE), loading 
capacity (LC), release profile and stability measurements). Below, are presented the results from 
the characterization of zein nanoparticles. 
 
4.2.2.1 Size, Polydispersity index (PDI) and Potential Zeta 
Table 4.3 shows values of particle size by z-average and by number distribution, PDI and zeta 
potential values for zein nanoparticles prepared with and without TOC. 
 
Table 4.3 – Particle size (by z-average and number), polydispersity (PDI) and zeta potential for zein 
nanoparticles with and without ( )-α-tocopherol (TOC). 
TOC content 
Particle Size 
PDI 
Zeta Potential 
(mV) z-average (nm) number (nm) 
Without 109.60   21.78 a 34.96   8.89 a 0.359   0.059 a 25.64   3.415 a 
With 116.50   28.32 a 50.22   6.70 b 0.285   0.093 b 26.08   2.513 a 
Values are expressed as mean   standard deviation. 
a,b – Different letters in same column indicate a statistically significant difference (p < 0.05) 
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The values of particle size of nanoparticles without TOC are smaller than nanoparticles with TOC, 
not presenting statistically significant difference (p>0.05) for particle size by z-average 
distribution. However, the values of particle size by number distribution are significantly different 
(p<0.05), increasing from 34.96 (  8.89) to 50.22 (  6.70) nm when TOC is added to the 
system. This fact can be explained by the presence of the TOC in the nanoparticle structure. 
However, an high TOC content can help the TOC molecules migrate to the internal parts of the 
nanoparticles, being establish proper interaction between the zein and TOC molecules which lead 
to molecules rearrangements in the molecular structure of nanoparticles to make more stable 
particles  (Naghibzadeh et al., 2010). PDI of nanoparticles with TOC is smaller than zein 
nanoparticles without TOC being approximately 0.2 and 0.359 (  0.059), respectively, indicating 
that the particle size of zein nanoparticles without TOC have more heterogeneous distribution. 
Table 4.3 shows the potential zeta of zein nanoparticles with and without vitamin. As can be seen 
the sample with TOC has a zeta potential similar than sample without TOC, not being statistically 
significant different. Positive zeta demonstrated that the system can be used as a targeted 
delivery system of TOC in vivo, due to interactions with negatively charged biological membranes 
that will improve stability in the presence of biological cations (Luo et al., 2011). 
In order to confirm the sizes obtained by DLS for zein nanoparticles was also used NTA, being 
the results presented in Table 4.4. 
Table 4.4 – Particle size (mean and mode) for zein nanoparticles with and without ( )-α-tocopherol (TOC) 
by NTA (NanoSight). 
TOC content 
Particle size (nm) 
Mean  Mode 
Without 116   56 88 
With 149   60 93 
Values obtained by software Nanoparticle Tracking Analysis (NTA) 
2.0 Build 127 expressed as mean   standard deviation. 
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The values obtained by NTA are consistent with the values of particle size obtained by DLS, being 
clear the increase of sizes when TOC is encapsulated in the system. However, the results 
obtained by z-average distribution in DLS are more similar with NTA results. This way, the 
analyses done in DLS for characterization of zein nanoparticles were considered the particles 
sizes by z-average distribution. 
 
4.2.2.2 Morphological observation 
Figure 4.7 shows the transmission electron microscopy photographs of the zein nanoparticles 
without and with TOC.  
 
   
   
Figure 4.7 - Transmission electron microscopy (TEM) images of zein nanoparticles:  (a) Scale bar: 0.2 µm, 
85000x and (b) Scale bar: 0.5 µm, 30000x without TOC and (c) Scale bar: 0.5 µm, 30000x; and (d) 
Scale bar: 0.5 µm, 20000x with TOC. 
TEM images presented in Figure 4.7 show zein nanoparticles formed with and without TOC being 
possible to see a structure with a continuous, compact, and uniform spherical shape. However, 
in Figure 4.7b and Figure 4.7d part of the nanoparticles were clumped and connected to each 
other and this fact can be caused by the low-energy method used in present work (Luo et al., 
(a) (b) 
(c) (d) 
AZEVEDO, MA (2013) 
DEVELOPMENT OF NANOSTRUCTURES FOR ENCAPSULATION OF VITAMINS | 57 
 
2012). These agglomerate of nanoparticles can be consider responsible for the PDI values 
obtained to the nanosystem, 0.359 (  0.059) for nanoparticles without TOC and 0.285 (  0.093) 
with TOC. Regarding of nanoparticles sizes, as can be seen in images, they are consistent with 
values obtained by DLS and NTA; being possible to observe an increase in size for vitamin-loaded 
nanoparticles. 
 
4.2.2.3 Encapsulation Efficiency and Loading Capacity 
EE and LC were determined after separation of nanoparticles with vitamin entrapped from the 
aqueous medium containing free vitamin. The values of EE and LC obtained were 
94.95 (  4.17) % and 8.53 (  1.90) %, respectively. These values are higher than those reported 
for other zein systems. Luo et al. (2011) with TOC obtained values of EE in the range 75 - 85 %, 
being the particles sizes between 200 and 800 nm. Luo et al. (2012) with vitamin D-loaded 
obtained EE and LC in the range 50 – 80 % and 1 – 4 %, respectively (Luo et al., 2012 and Luo 
et al., 2011). So, the results obtained show that zein nanoparticles obtained by self-assembly 
present good values of EE and LC, being that 94.95 (  4.17) % of content TOC are encapsulated 
in zein nanoparticles and the high LC evidenced the electrostatic interactions between TOC and 
zein (Luo et al., 2011).  
 
4.2.2.4 Release Profile of TOC from zein nanoparticles 
The release properties of the TOC from the zein nanoparticles were experimentally determined by 
measuring the concentration of the TOC in the release media as a function of time. For this was 
also used a dialysis membrane method and the release experiments were conducted at 37°C 
and the media utilized was PBS (pH 7) and Tris-HCl (pH 2). A better understanding of the 
mechanism of TOC release from zein nanoparticles was obtained by analysis using the Eq.3.3 
and it is possible to observe in Figure 4.8 a good agreement between experimental and model-
generated values, suggesting that this mathematical model describes well the mechanism.  
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Figure 4.8 – Fitting of Eq. 3.3 to TOC controlled release experimental data from zein nanoparticles at 
37°C, pH 2 ((•) experimental results  and ( o ) model-generated values). 
Into the PBS of pH 7, the TOC are not released and the hydrophobic interactions may also have 
contributed for this fact because zein is hydrophobic. In addition, as zein is a protein and has an 
isoelectric point of 6.8, zein is positively charged at pH 2-6 and negatively charged at pH 7-8. So, 
as TOC has a low positively charge, in pH 7 the overall electrostatic interactions between zein 
and TOC become attractive, which, together with stronger hydrophobic interactions, resulted in 
not release (Zhong et al., 2009). However, the Figure 4.8 shows that TOC was release in Tris-HCl 
of pH 2 and the release profile just have a “lag time” phase, release continuous and slow, being 
the diffusion coefficient for TOC release 2.8    -   m  s. This fact can also be explained by 
overall electrostatic interactions between zein and TOC, because as pH 2 the zein has a negative 
charge, the interactions are repulsive between zein and TOC and as result have a slow TOC 
release (Zhong et al., 2009). Moreover, when zein nanoparticles were into the buffer Tris-HCL, 
the particles can form aggregates that can be gradually dispersed and completely dissolved, so 
this fact can be other reason for TOC release in Tris-HCl medium (Parris et al., 2005; Somchue 
et al., 2009). 
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4.2.2.5 Stability 
Temperature 
Figure 4.9 shows the effect of temperature in zein nanoparticles size and PDI and, as can be 
seen, the temperature cause the increase of sizes and decrease of PDI (p<0.05). An explanation 
for increase of nanoparticles size is the hydrophobic interactions between zein molecules, being 
these interactions caused by ethanol evaporation. As ethanol is evaporated at a faster than water 
(ethanol boiling point at 78.37°C), the increase of temperature results in ethanol evaporation 
and, consequently, self-assembly was modeled from the hydrophobic and hydrophilic 
contributions to the interfacial free energy from zein and solvent. This way, with increase of 
temperature the solvent became more hydrophilic that results in changes of solvent polarity 
(considered the main driving force for zein self-assembly) and in increase of nanoparticles (Wang 
and Padua, 2012a, 2012b).  
Temperature is a variable important for many proteins because the proteins denature at high 
temperatures and when zein is heated to 70 °C the secondary structure changes (Selling et al., 
2007). As can be seen in Figure 4.9, the significant increase of sizes is from 70 °C, this way 
other explanation for increase of nanoparticles size is denaturation of zein.  
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Figure 4.9 – Effect of temperature in particle size and PDI of zein nanoparticles without TOC. 
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Storage Time 
Zein nanoparticles stability was studied during five months, being used DLS for measurement of 
size and PDI of nanoparticles. Figure 4.10 shows the effect of time in sizes and PDI of particles 
with and without vitamin. Results show that encapsulation of TOC do not interfere with stability of 
zein nanoparticles, presenting the samples the same stability profile. Initially, after the first month 
of storage the sizes of nanoparticles increase and PDI decrease, being the results obtained for 
first and the second month statistically different (p<0.05). Then zein nanoparticles sizes and PDI 
are constant from the second to the fifth month not changing particles size and PDI values 
(p>0.05).  
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Figure 4.10 – Stability of Zein nanoparticles: (a) without TOC; (b) with TOC. 
(a) 
(b) 
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5.1 CONCLUSIONS 
The main objective of this work was to develop nanostructures for the encapsulation of water-
soluble and liposoluble vitamins and their further characterization. So, and in order to cover this 
objective two types of nanoparticles were studied: alginate/chitosan nanoparticles for 
encapsulation of water-soluble vitamins, and zein nanoparticles for liposoluble vitamins. 
First, for alginate/chitosan nanoparticles, the interesting features of this work were the following: 
- Pre-gelation ionotropic method can be used for alginate/chitosan nanoparticles 
production, however it has been demonstrated the importance of various parameters during the 
preparation of nanoparticles. 
- (-)-Riboflavin can be successfully encapsulated with values of EE and LC of ~55 % and 
~2 %, respectively.  
- Release profiles showed that alginate/chitosan nanoparticles can be used in the 
retention of (-)-riboflavin. 
Essentially, the results show that ionotropic pre-gelation is a promising approach to produce 
alginate/chitosan nanoparticles with vitamin and the nanoparticles show potential to be applied 
in different food and/or beverages products.  
For zein nanoparticles, the main conclusions were: 
- Zein nanoparticles were successfully developed as a novel delivery system for TOC, using 
a low-energy method self-assembly.  
- Particle size and PDI of the nanostructure can be controlled with different preparation 
parameters. 
- TOC was encapsulated without significant influence on particle size, being obtained 
values of EE of ~95 % and LC of ~9.  
- The TOC was not release in PBS medium at 37°C but was in Tris-HCL medium. 
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Briefly, the zein nanoparticles are a good option for TOC encapsulation, but it is necessary an 
optimization to protect TOC against premature release in gastric pH and the release in intestine. 
 
5.2 RECOMMENDATIONS 
In general, the main objectives of this thesis have been achieved, however some work can be 
done in order to better understand the properties of the nanoparticles developed and how can 
they be used in food industry. So, some recommendations for improvement of the present work 
can be advanced: 
- Nanoparticles characteristics and the relationship between vitamins and biopolymers can 
be achieved, for example, by FTIR (Fourier Transform Infrared Spectroscopy), DSC (Differential 
Scanning Calorimetry) and/or TGA (Thermogravimetric analysis). 
- As both vitamins used lost their properties when exposed to the light, in order to perceive 
the differences between free vitamin and vitamin encapsulated, it can be interesting to do a 
photochemical stability measurement.  
- Generally, most nutrients and vitamins are best absorbed in intestine for further 
utilization in the body. So, it is important to protect vitamins against premature release in gastric 
pH and to promote the release in intestine. This way, particularly for zein nanoparticles, I suggest 
a coating with, for example, chitosan or alginate.  
- A release profile at 25°C in PBS and Tris-HCL medium could be useful in order to know if 
the temperature influences the release of TOC.   
- Also it can be important to use a dynamic gastro-intestinal model that mimics the human 
physiological conditions (simulating of stomach, duodenum, jejunum and ileum) to evaluate the 
influence of physiological parameters, such as pH, temperature, peristaltic movements, secretion 
of digestion enzymes, bile an pancreatic juice, in both nanoparticles developed. This would allow 
having a clear idea clearest of what happen with nanoparticles in our organism.  
- The toxicity of nanoparticles represents one of the major problems for nanotechnology, 
so, the in vitro and in vivo evaluation of alginate/chitosan and zein nanoparticles in different cell 
line and animal models can be an interesting work. 
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ANNEX A 
OPTIMIZATION OF DEVELOPMENT OF NANOPARTICLES  
I. ALGINATE/CHITOSAN NANOPARTICLES 
Table A.1 – Different formulations tested for development of alginate/chitosan nanoparticles.  
Formulation 
Alginate 
(%) 
Flow rate 
of CaCl2 
(mL/min) 
Chitosan 
(%) 
Flow rate of 
chitosan solution 
(mL/min) 
Ultra-
Turrax 
(rpm) 
Centrifugation 
at the end of 
process 
1 0.063 0.085 0.07 0.189 0 
1 min at 14 000 
rpm 
2 0.063 0.125 0.07 0.278 0 
1 min at 14 000 
rpm 
3 0.063 0.125 0.07 0.278 0 No 
4 0.063 0.125 0.07 0.278 20 000 No 
5 0.063 0.125 0.07 0.278 20 000 
10 min at 14 
000 rpm 
6 0.063 0.125 0.04 0.278 20 000 No 
7 0.063 0.125 0.04 0.278 20 000 
10 min at 14 
000 rpm 
8 0.063 0.125 0.02 0.278 20 000 No 
9 0.063 0.125 0.02 0.278 20 000 
10 min at 14 
000 rpm 
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Table A.2 – Particle size and PDI values of different formulations for development of alginate/chitosan 
nanoparticles. 
Formulation 
Particle Size  
(nm) 
PDI 
1 480.93   13.84 0.542   0.075 
2 1115.83   108.05 0.955   0.078 
3 412.13   11.52 0.516   0.015 
4 863.57   34.92 0.842   0.019 
5 389.97   6.92 0.400   0.052 
6 539.27   17.55 0.449   0.031 
7 296.77   16.84 0.363   0.031 
8 699.93   63.84 0.581   0.053 
9 292.63   5.59 0.438   0.014 
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II. ZEIN NANOPARTICLES 
Table A.3 – Different formulations testes for development of zein nanoparticles. 
Formulation 
Zein  
(mg/mL) 
Ratio 
Zein solution:distilled water 
(v/v) 
Flow Rate  
(mL/min) 
( )-α-Tocopherol 
(mg/mL) 
1 2 1:1 0.667 0 
2 2 1:2 0.667 0 
3 2 1:5 0.667 0 
4 2 1:10 0.667 0 
5 2 2:1 0.667 0 
6a 2 1:5 0.667 0 
7b 2 1:5 0.333 0 
8c 2 1:5 0.333 1 
9c 2 1:5 0.222 0 
10c 2 1:5 0.167 0 
11c 2 1:5 0.167 1 
12c 1 1:5 0.167 0 
13d 1 1:5 0.167 0.5 
 
After zein solution addition, zein nanoparticles were maintained in the same stirring for 60 minutes and 
was measured the size and PDI at the time: 
a 0, 5, 15, 25, 30, 45 and 60 minutes. 
b 0, 5, 15, 30 and 60 minutes. 
c 0, 5, 15, 25, 30, 45 and 60 minutes. 
d In the end of the procedure the zein nanoparticles was maintained in same stirring for 15 minutes, 
being measured the size and PDI. 
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Table A.4 – Particle size and PDI values of different formulations for development of zein nanoparticles. 
Formulation 
Particle Size 
(nm) 
PDI Formulation 
Particle Size 
(nm) 
PDI 
1 491.13   17.93 0.238    . 3  8.5 161.77   6.98 0.408    .    
2 223.73   7.87 0.201   0.019 9 305.60     .   0.358    .  3 
3 138.23   10.88 0.361   0.127 9.1 181.17   19.79 0.244    .    
4 480.33   258.25 0.462   0.199 9.2 320.77    3 .   0.340   0.087 
5 738.50   44.98 0.252    .    9.3 218.83   44.18 0.266    .    
6.1 190.53   13.64 0.459   0.027 9.4 475.83      .   0.460   0.193 
6.2 251.400   33.   0.512    .    9.5 207.63   35.11 0.277   0.073 
6.3 177.37   3.   0.447   .    10 231.77   3 .   0.313    . 3  
6.4 224.57   11.59 0.543    .    10.1 278.30   101.06 0.360   0.065 
6.5 208.27     .   0.425    .    10.2 102.50   15.35 0.426    .    
6.6 203.97   26.27 0.471    .    10.3 405.77      .   0.415    . 3  
7 126.83    . 3 0.464    .    10.4 140.33    .   0.197    .    
7.1 150.30    .   0.479    .    10.5 231.13   36.53 0.277    . 3  
7.2 147.03   7.94 0.455    .    11 94.71    .   0.298    .    
7.3 219.67     .   0.340   0.152 11.1 189.10   43.48 0.232    .    
7.4 266.63     .   0.271    . 3  11.2 90.61   1.35 0.257    .    
8 136.83    .   0.364    .    11.3 102.68   14.74 0.253    .    
8.1 176.40    3.   0.254   0.015 11.4 172.37   20.40 0.334    .    
8.2 154.37    .   0.414    .    12 117.13   0.59 0.412    .    
8.3 145.60    .   0.367    .    13 116.80   0.82 0.284    .    
8.4 142.03    .   0.377    .       
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ANNEX B 
MAXIMUM ABSORBANCE PEAK 
I. (-)-RIBOFLAVIN  
200 300 400 500 600 700
0
1
2
3
4
5
Wavelenght (nm)
A
b
s
 
Figure A.1 – UV–Vis spectrum of (-)-riboflavin. Spectra were overlaid after scanning from 200 to 600 nm. 
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II. ( )-α-TOCOPHEROL 
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Figure A.2 – UV–Vis spectrum of TOC. Spectra were overlaid after scanning from 200 to 400 nm. 
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ANNEX C  
CALIBRATION CURVES  
I. (-)-RIBOFLAVIN  
Table A.5 – Dilutions and their absorbance values for calibration curve of (-)-riboflavin. 
 
0.000 0.005 0.010 0.015 0.020
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
(-)-Riboflavin (mg/ml)
A
b
s
 
Figure A.3 – Calibration curve of (-)-riboflavin. Absorbance versus concentration for (-)-riboflavin. 
  
 
Dilution 
0 1/2 1/4 1/5 1/8 1/10 1/16 1/25 1/32 1/100 1/125 
[(-)-Riboflavin] 
(mg/ml) 
0.0950 0.0475 0.0238 0.0190 0.0119 0.0095 0.0059 0.0038 0.0030 
0.001
0 
0.0008 
Absorbance 
(λ 437 nm) 2.465 1.488 0.738 0.642 0.343 0.311 0.186 0.130 0.088 0.033 0.025 
Y   33.77x - 0.0049 
R2  0.999 
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II. ( )-α-TOCOPHEROL 
Table A. 6 – Dilutions and their absorbance values for calibration curve of TOC. 
 
Dilution 
0 1/2 1/4 1/5 1/10 1/16 1/25 1/32 1/100 1/125 1/150 1/1000 
[TOC] 
(mg/mL) 
0.500 0.250 0.125 0.100 0.063 0.05 0.031 0.020 0.016 0.005 0.004 0.0005 
Absorbance 
(λ 292 nm) 2.466 1.811 1.105 0.883 0.507 0.636 0.323 0.287 0.182 0.046 0.030 0.001 
 
0.00 0.02 0.04 0.06 0.08 0.10
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
(mg/ml) OCT
A
b
s
 
Figure A.4 – Calibration curve of (±)-α-tocopherol. Absorbance versus concentration for (±)-α-tocopherol. 
 
Y   7.5582x + 0.0004 
R2  0.997 
